<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Levonorgestrel</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Levonorgestrel">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Levonorgestrel</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Levonorgestrel</b> is a hormonal medication which is used in a number of birth control methods.<span class="mw-ref" id="cite_ref-AHFS2015_5-0"><a href="#cite_note-AHFS2015-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> It is combined with an <a href="Estrogen.htm" tppabs="https://ptable.com/wiki/compounds/A/Estrogen" title="Estrogen">estrogen</a> to make combination birth control pills.<span class="mw-ref" id="cite_ref-6"><a href="#cite_note-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> As an emergency birth control, sold under the brand name <b>Plan B</b> among others, it is useful within 120 hours of unprotected sex.<span class="mw-ref" id="cite_ref-AHFS2015_5-1"><a href="#cite_note-AHFS2015-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> The more time that has passed since sex, the less effective the medication becomes, and it does not work after pregnancy (implantation) has occurred.<span class="mw-ref" id="cite_ref-AHFS2015_5-2"><a href="#cite_note-AHFS2015-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> It decreases the chances of pregnancy by 57 to 93%.<span class="mw-ref" id="cite_ref-Gem2010_7-0"><a href="#cite_note-Gem2010-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> In an intrauterine device (IUD), such as <b>Mirena</b> among others, it is effective for the long-term prevention of pregnancy.<span class="mw-ref" id="cite_ref-AHFS2015_5-3"><a href="#cite_note-AHFS2015-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> A levonorgestrel-releasing implant is also available in some countries.<span class="mw-ref" id="cite_ref-8"><a href="#cite_note-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span></p>


<div role="note" class="hatnote navigation-not-searchable">Not to be confused with <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Norgestrel  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Norgestrel'" tppabs="https://ptable.com/wiki/compounds/A/Norgestrel" title="Norgestrel">Norgestrel</a>.</div>

<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Levonorgestrel</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Levonorgestrel.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Levonorgestrel.svg.png" data-file-width="512" data-file-height="374" data-file-type="drawing" height="164" width="225"></figure-inline></td></tr><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Levonorgestrel_molecule_ball.png" tppabs="https://ptable.com/wiki/compounds/I/m/Levonorgestrel_molecule_ball.png" data-file-width="2560" data-file-height="1923" data-file-type="bitmap" height="177" width="235"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Plan B, others</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Other names</th><td>LNG; d-Norgestrel; d(–)-Norgestrel; <small>D</small>-Norgestrel; WY-5104; SH-90999; NSC-744007; 18-Methylnorethisterone; 17α-Ethynyl-18-methyl-19-nortestosterone; 17α-Ethynyl-18-methylestr-4-en-17β-ol-3-one; 13β-Ethyl-17α-hydroxy-18,19-dinorpregn-4-en-20-yn-3-one</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/monograph/progestins-etonogestrel-levonorgestrel-norethindrone.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/progestins-etonogestrel-levonorgestrel-norethindrone.html'" tppabs="https://www.drugs.com/monograph/progestins-etonogestrel-levonorgestrel-norethindrone.html" class="external text external">Monograph</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">MedlinePlus</th><td><span><a href="javascript:if(confirm('https://medlineplus.gov/druginfo/meds/a610021.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://medlineplus.gov/druginfo/meds/a610021.html'" tppabs="https://medlineplus.gov/druginfo/meds/a610021.html" class="external text external">a610021</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>B3<span> </span><span class="mw-ref" id="cite_ref-Drugs.com_pregnancy_1-0"><a href="#cite_note-Drugs.com_pregnancy-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>N (Not classified yet)<span> </span><span class="mw-ref" id="cite_ref-Drugs.com_pregnancy_1-1"><a href="#cite_note-Drugs.com_pregnancy-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></li></ul>

<ul><li>Contraindicated<span class="mw-ref" id="cite_ref-Drugs.com_pregnancy_1-2"><a href="#cite_note-Drugs.com_pregnancy-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>By mouth, transdermal patch, intrauterine device, subcutaneous implant</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Drug class</th><td>Progestogen (medication); Progestin</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>G03AC03<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=G03AC03  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=G03AC03'" tppabs="https://www.whocc.no/atc_ddd_index/?code=G03AC03" class="external text external">WHO</a></span>)<span> </span>G03AD01<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=G03AD01  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=G03AD01'" tppabs="https://www.whocc.no/atc_ddd_index/?code=G03AD01" class="external text external">WHO</a></span>)</li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">US</abbr>:</small><span> </span>℞-only<span> </span>/<span>&nbsp;</span>OTC</li>
<li>In<span>&nbsp;</span>general: ℞<span>&nbsp;</span>(Prescription only)</li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Bioavailability</th><td>95% (range 85–100%)<span class="mw-ref" id="cite_ref-pmid16112947_2-0"><a href="#cite_note-pmid16112947-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-pmid8842581_3-0"><a href="#cite_note-pmid8842581-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Protein binding</th><td>98% (50% to <a href="Human_serum_albumin.htm" tppabs="https://ptable.com/wiki/compounds/A/Human_serum_albumin" title="Human serum albumin">albumin</a>, 48% to <abbr>SHBG</abbr>)<span class="mw-ref" id="cite_ref-pmid16112947_2-1"><a href="#cite_note-pmid16112947-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>Liver (reduction, hydroxylation, conjugation)<span class="mw-ref" id="cite_ref-pmid16112947_2-2"><a href="#cite_note-pmid16112947-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-ShoupeHaseltine2012_4-0"><a href="#cite_note-ShoupeHaseltine2012-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolites</th><td>• 5α-Dihydro-<abbr>LNG</abbr><span class="mw-ref" id="cite_ref-pmid16112947_2-3"><a href="#cite_note-pmid16112947-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>24–32 hours<span class="mw-ref" id="cite_ref-pmid16112947_2-4"><a href="#cite_note-pmid16112947-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>Urine: 20–67%<br>Feces: 21–34%<span class="mw-ref" id="cite_ref-ShoupeHaseltine2012_4-1"><a href="#cite_note-ShoupeHaseltine2012-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">(8<i>R</i>,9<i>S</i>,10<i>R</i>,13<i>S</i>,14<i>S</i>,17<i>R</i>)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[<i>a</i>]phenanthren-3-one</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=797-63-7  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=797-63-7'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=797-63-7" class="external text external">797-63-7</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/13109  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/13109'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/13109" class="external text external">13109</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">IUPHAR/BPS</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2881  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2881'" tppabs="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2881" class="external text external">2881</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB00367  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB00367'" tppabs="https://www.drugbank.ca/drugs/DB00367" class="external text external">DB00367</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.12560.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.12560.html'" tppabs="http://www.chemspider.com/Chemical-Structure.12560.html" class="external text external">12560</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=5W7SIA7YZW  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=5W7SIA7YZW'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=5W7SIA7YZW" class="external text external">5W7SIA7YZW</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D00950  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D00950'" tppabs="https://www.kegg.jp/entry/D00950" class="external text external">D00950</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEBI</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:6443  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:6443'" tppabs="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:6443" class="external text external">CHEBI:6443</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1389  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1389'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1389" class="external text external">ChEMBL1389</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID3036496  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID3036496'" tppabs="https://comptox.epa.gov/dashboard/DTXSID3036496" class="external text external">DTXSID3036496</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;"><span>ECHA InfoCard</span></th><td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.011.227  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.011.227'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.011.227" class="external text external">100.011.227</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>21</sub><span>H</span><sub>28</sub><span>O</span><sub>2</sub></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">312.453</span><span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=CC%5BC%40%5D12CC%5BC%40H%5D3%5BC%40H%5D%28%5BC%40%40H%5D1CC%5BC%40%5D2%28C%23C%29O%29CCC4%3DCC%28%3DO%29CC%5BC%40H%5D34  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=CC%5BC%40%5D12CC%5BC%40H%5D3%5BC%40H%5D%28%5BC%40%40H%5D1CC%5BC%40%5D2%28C%23C%29O%29CCC4%3DCC%28%3DO%29CC%5BC%40H%5D34'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=CC%5BC%40%5D12CC%5BC%40H%5D3%5BC%40H%5D%28%5BC%40%40H%5D1CC%5BC%40%5D2%28C%23C%29O%29CCC4%3DCC%28%3DO%29CC%5BC%40H%5D34" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Melting point</th><td>235 to 237<span>&nbsp;</span>°C (455 to 459<span>&nbsp;</span>°F)</td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C21H28O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h2,13,16-19,23H,3,5-12H2,1H3/t16-,17+,18+,19-,20-,21-/m0/s1<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:WWYNJERNGUHSAO-XUDSTZEESA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=462091161&page2=Levonorgestrel  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=462091161&page2=Levonorgestrel'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=462091161&page2=Levonorgestrel" class="external text external">(verify)</a></span></span></td></tr></tbody></table>

<p>Common side effects include nausea, breast tenderness, headaches, and increased, decreased, or irregular menstrual bleeding.<span class="mw-ref" id="cite_ref-AHFS2015_5-4"><a href="#cite_note-AHFS2015-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> When used as an emergency contraceptive, if pregnancy occurs, there is no evidence that its use harms the baby.<span class="mw-ref" id="cite_ref-AHFS2015_5-5"><a href="#cite_note-AHFS2015-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> It is safe to use during breastfeeding.<span class="mw-ref" id="cite_ref-AHFS2015_5-6"><a href="#cite_note-AHFS2015-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> Birth control that contains levonorgestrel will not change the risk of sexually transmitted infections.<span class="mw-ref" id="cite_ref-AHFS2015_5-7"><a href="#cite_note-AHFS2015-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> It is a progestin and has effects similar to those of the hormone <a href="Progesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Progesterone" title="Progesterone">progesterone</a>.<span class="mw-ref" id="cite_ref-AHFS2015_5-8"><a href="#cite_note-AHFS2015-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> It works primarily by preventing ovulation and closing off the cervix to prevent the passage of sperm.<span class="mw-ref" id="cite_ref-AHFS2015_5-9"><a href="#cite_note-AHFS2015-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span></p>


<p>Levonorgestrel was patented in 1960 and introduced for medical use together with ethinylestradiol in 1970.<span class="mw-ref" id="cite_ref-Fis2006_9-0"><a href="#cite_note-Fis2006-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span><span class="mw-ref" id="cite_ref-Roth2014_10-0"><a href="#cite_note-Roth2014-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> It is on the World Health Organization's List of Essential Medicines, the safest and most effective medicines needed in a health system.<span class="mw-ref" id="cite_ref-WHO21st_11-0"><a href="#cite_note-WHO21st-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> It is available as a generic medication.<span class="mw-ref" id="cite_ref-Ric2014_12-0"><a href="#cite_note-Ric2014-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> In the United States, levonorgestrel-containing emergency contraceptives are available over the counter (OTC) for all ages.<span class="mw-ref" id="cite_ref-13"><a href="#cite_note-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> In 2016, it was the 223rd most commonly prescribed medication in the United States, with more than two million prescriptions.<span class="mw-ref" id="cite_ref-14"><a href="#cite_note-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span></p>
<style data-mw-deduplicate="TemplateStyles:r886046785">.mw-parser-output .toclimit-2 .toclevel-1 ul,.mw-parser-output .toclimit-3 .toclevel-2 ul,.mw-parser-output .toclimit-4 .toclevel-3 ul,.mw-parser-output .toclimit-5 .toclevel-4 ul,.mw-parser-output .toclimit-6 .toclevel-5 ul,.mw-parser-output .toclimit-7 .toclevel-6 ul{display:none}</style><div class="toclimit-3"><meta property="mw:PageProp/toc"></div>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_uses">Medical uses</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Birth_control">Birth control</h3></summary>
    


<p>At low doses, levonorgestrel is used in monophasic and triphasic formulations of combined oral contraceptive pills, with available monophasic doses ranging from 100–250<span>&nbsp;</span>µg, and triphasic doses of 50<span>&nbsp;</span>µg/75<span>&nbsp;</span>µg/125<span>&nbsp;</span>µg.<span class="mw-ref" id="cite_ref-Drugs.com_15-0"><a href="#cite_note-Drugs.com-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span> It is combined with the estrogen ethinylestradiol in these formulations.<span class="mw-ref" id="cite_ref-Drugs.com_15-1"><a href="#cite_note-Drugs.com-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></p>

<p>At very low daily dose of 30<span>&nbsp;</span>µg, levonorgestrel is used in some <a href="Progestogen-only_pill.htm" tppabs="https://ptable.com/wiki/compounds/A/Progestogen-only_pill" title="Progestogen-only pill">progestogen-only pill</a> 
formulations.<span class="mw-ref" id="cite_ref-Drugs.com_15-2"><a href="#cite_note-Drugs.com-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></p>

<p>Levonorgestrel is the active ingredient in a number of intrauterine devices including Mirena and Skyla.<span class="mw-ref" id="cite_ref-Drugs.com_15-3"><a href="#cite_note-Drugs.com-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span><span class="mw-ref" id="cite_ref-pmid26732558_16-0"><a href="#cite_note-pmid26732558-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span> It is also the active ingredient in the birth control implants Norplant and Jadelle.<span class="mw-ref" id="cite_ref-Drugs.com_15-4"><a href="#cite_note-Drugs.com-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span><span class="mw-ref" id="cite_ref-pmid26732558_16-1"><a href="#cite_note-pmid26732558-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span></p>

<p>One of the more common forms of contraception that contains only levonorgestral is an IUD. One IUD, the Mirena is a small hollow cylinder containing levonorgestral and polydimethylsiloxane and covered with a release rate controlling membrane.<span class="mw-ref" id="cite_ref-Bao_Q_2018_17-0"><a href="#cite_note-Bao_Q_2018-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Emergency_birth_control">Emergency birth control</h3></summary>
    
<p>Levonorgestrel is used in emergency contraceptive pills (ECPs), both in a combined Yuzpe regimen which includes estrogen, and as a levonorgestrel-only method. The levonorgestrel-only method uses levonorgestrel 1.5<span>&nbsp;</span>mg (as a single dose or as two 0.75<span>&nbsp;</span>mg doses 12 hours apart) taken within 3 days of unprotected sex, with one study indicating that beginning as late as 120 hours (5 days) after intercourse could be effective.</p>

<p>The primary mechanism of action of levonorgestrel as a progestogen-only emergency contraceptive pill is, according to International Federation of Gynecology and Obstetrics (FIGO), to prevent fertilization by inhibition of ovulation and thickening of cervical mucus.<span class="mw-ref" id="cite_ref-Trussell_2011_18-0"><a href="#cite_note-Trussell_2011-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span><span class="mw-ref" id="cite_ref-FSRH_EC_2012_19-0"><a href="#cite_note-FSRH_EC_2012-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span><span class="mw-ref" id="cite_ref-WHO_2010_20-0"><a href="#cite_note-WHO_2010-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span><span class="mw-ref" id="cite_ref-Speroff_2011_21-0"><a href="#cite_note-Speroff_2011-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span> FIGO has stated that: "review of the evidence suggests that LNG [levonorgestreol] ECPs cannot prevent implantation of a fertilized egg. Language on implantation should not be included in LNG ECP product labeling."<span class="mw-ref" id="cite_ref-Belluck_2012b_22-0"><a href="#cite_note-Belluck_2012b-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span><span class="mw-ref" id="cite_ref-FIGO_2011_23-0"><a href="#cite_note-FIGO_2011-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span> In November 2013, the European Medicines Agency (EMA) approved a change to the label saying it cannot prevent implantation of a fertilized egg.<span class="mw-ref" id="cite_ref-Belluck_2013_24-0"><a href="#cite_note-Belluck_2013-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span></p>

<p>Other studies still find the evidence to be unclear.<span class="mw-ref" id="cite_ref-25"><a href="#cite_note-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span> While it is unlikely that emergency contraception affects implantation it is impossible to completely exclude the possibility of post-fertilization effect.<span class="mw-ref" id="cite_ref-26"><a href="#cite_note-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span></p>

<p>In November 2013, the EMA also approved a change to the label for HRA Pharma's <i>NorLevo</i> saying: "In clinical trials, contraceptive efficacy was reduced in women weighing 75 kg [165 pounds] or more, and levonorgestrel was not effective in women who weighed more than 80 kg [176 pounds]."<span class="mw-ref" id="cite_ref-Belluck_2013_24-1"><a href="#cite_note-Belluck_2013-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span><span class="mw-ref" id="cite_ref-Glasier_2011_27-0"><a href="#cite_note-Glasier_2011-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span><span class="mw-ref" id="cite_ref-Trussell_2014_28-0"><a href="#cite_note-Trussell_2014-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span> In November 2013 and January 2014, the FDA and the EMA said they were reviewing whether increased weight and body mass index (BMI) reduce the efficacy of emergency contraceptives.<span class="mw-ref" id="cite_ref-Belluck_2013_24-2"><a href="#cite_note-Belluck_2013-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span></p>

<p>An analysis of four WHO randomised clinical trials, published in January 2017, showed pregnancy rates of 1.25% (68/5428) in women with BMI under 25, 0.61% (7/1140) in women with BMI between 25 and 30, and 2.03% (6/295) in women with BMI over 30.<span class="mw-ref" id="cite_ref-29"><a href="#cite_note-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span> These values yield an eight-fold reduction in efficacy for women with BMI over 30 compared to women with BMI under 25. However, emergency contraceptives remain effective regardless of BMI.</p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Hormone_therapy">Hormone therapy</h3></summary>
    
<p>Levonorgestrel is used in combination with an estrogen in menopausal hormone therapy.<span class="mw-ref" id="cite_ref-Drugs.com_15-5"><a href="#cite_note-Drugs.com-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span><span class="mw-ref" id="cite_ref-Kubíková2014_30-0"><a href="#cite_note-Kubíková2014-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span> It is used under the brand name <i>Klimonorm</i> as a combined oral tablet with estradiol valerate and under the brand name <i>Climara Pro</i> as a combined transdermal patch with estradiol.<span class="mw-ref" id="cite_ref-Drugs.com_15-6"><a href="#cite_note-Drugs.com-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span><span class="mw-ref" id="cite_ref-Kubíková2014_30-1"><a href="#cite_note-Kubíková2014-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Available_forms">Available forms</h3></summary>
    
<p>As a type of emergency contraception, levonorgestrel is used after unprotected intercourse to reduce the risk of pregnancy.<span class="mw-ref" id="cite_ref-Emergency_Contraception_-_ACOG_31-0"><a href="#cite_note-Emergency_Contraception_-_ACOG-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span> However, it can serve different hormonal purposes in its different methods of delivery. It is available for use in a variety of forms:</p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="By_mouth">By mouth</h4></summary>
    
<p>Levonorgestrel can be taken by mouth as a form of emergency birth control. The typical dosage is either 1.5<span>&nbsp;</span>mg taken once or 0.75<span>&nbsp;</span>mg taken 12–24 hours apart.<span class="mw-ref" id="cite_ref-:0_32-0"><a href="#cite_note-:0-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span> The effectiveness in both methods is similar.<span class="mw-ref" id="cite_ref-:0_32-1"><a href="#cite_note-:0-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span> The most widely used form of oral emergency contraception is the <a href="Progestogen-only_pill.htm" tppabs="https://ptable.com/wiki/compounds/A/Progestogen-only_pill" title="Progestogen-only pill">progestin-only pill</a>, which contains a 1.5<span>&nbsp;</span>mg dosage of levonorgestrel.<span class="mw-ref" id="cite_ref-Emergency_Contraception_-_ACOG_31-1"><a href="#cite_note-Emergency_Contraception_-_ACOG-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span> Levonorgestrel-only emergency contraceptive pills are reported to have an 89% effectiveness rate if taken within the recommended 72 hours after sex.<span class="mw-ref" id="cite_ref-:1_33-0"><a href="#cite_note-:1-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span> The efficacy of the drug decreases by 50% for each 12 hour delay in taking the dose after the emergency contraceptive regimen has been started.<span class="mw-ref" id="cite_ref-:1_33-1"><a href="#cite_note-:1-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Skin_patch">Skin patch</h4></summary>
    


<p>Estradiol with levonorgestrel in the form of a skin patch is used under the brand name Climara Pro for hormone replacement therapy in postmenstrual women, treating symptoms such as hot flashes or osteoporosis.<span class="mw-ref" id="cite_ref-:2_34-0"><a href="#cite_note-:2-34" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span> The simultaneous delivery of a progestogen such as levonorgestrel is necessary for the protection of the endometrium.<span class="mw-ref" id="cite_ref-:3_35-0"><a href="#cite_note-:3-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span><span class="mw-ref" id="cite_ref-36"><a href="#cite_note-36" style="counter-reset: mw-Ref 36;"><span class="mw-reflink-text">[36]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Intrauterine_device">Intrauterine device</h4></summary>
    
<p>The levonorgestrel intrauterine system (LNG-IUS) is a type of long-term birth control that releases the progestin into the uterine cavity.<span class="mw-ref" id="cite_ref-Jeff2005_37-0"><a href="#cite_note-Jeff2005-37" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span><span class="mw-ref" id="cite_ref-Bao_Q_2018_17-1"><a href="#cite_note-Bao_Q_2018-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> Levonorgestrel is released at a constant, gradual rate of 0.02<span>&nbsp;</span>mg per day by the polydimethylsiloxane membrane of the device, which renders it effective for up to 5 years.<span class="mw-ref" id="cite_ref-Jeff2005_37-1"><a href="#cite_note-Jeff2005-37" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span> Because it is inserted directly into the uterus, levonorgestrel is present in the endometrium in much higher concentrations that would result from a LNG-containing oral pill; the LNG-IUS delivers 391<span>&nbsp;</span>ng of levonorgestrel to the inner uterine region while a comparable oral contraceptive delivers only 1.35<span>&nbsp;</span>ng.<span class="mw-ref" id="cite_ref-Jeff2005_37-2"><a href="#cite_note-Jeff2005-37" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span> This high level of levonorgestrel impedes the function of the endometrium, making it hostile for sperm transport, fertilization, and implantation of an ovum.<span class="mw-ref" id="cite_ref-Jeff2005_37-3"><a href="#cite_note-Jeff2005-37" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Implant">Implant</h4></summary>
    
<p>Subcutaneous implants of levonorgestrel have been marketed as birth control implants under the brand names Norplant and Jadelle and are available for use in some countries.<span class="mw-ref" id="cite_ref-pmid18803473_38-0"><a href="#cite_note-pmid18803473-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span><span class="mw-ref" id="cite_ref-Drugs.com_15-7"><a href="#cite_note-Drugs.com-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Contraindications">Contraindications</h2></summary>
    
<p>Known or suspected pregnancy is a contraindication of levonorgestrel as an emergency contraceptive.<span class="mw-ref" id="cite_ref-PlanB_One-Step-Label_39-0"><a href="#cite_note-PlanB_One-Step-Label-39" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Side_effects">Side effects</h2></summary>
    


<p>After an intake of 1.5<span>&nbsp;</span>mg levonorgestrel in clinical trials, very common side effects (reported by 10% or more) included: hives, dizziness, headache, nausea, abdominal pain, uterine pain, delayed menstruation, heavy menstruation, uterine bleeding, and fatigue; common side effects (reported by 1% to 10%) included diarrhea, vomiting, and painful menstruation; these side effects usually disappeared within 48<span>&nbsp;</span>hours.<span class="mw-ref" id="cite_ref-40"><a href="#cite_note-40" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span><span class="mw-ref" id="cite_ref-pmid24708811_41-0"><a href="#cite_note-pmid24708811-41" style="counter-reset: mw-Ref 41;"><span class="mw-reflink-text">[41]</span></a></span> However, the long term side effects common with oral contraceptives such as arterial disease are lower with levonorgestrel than in combination pills.</p>

<p>Levonorgestrel as a contraceptive intrauterine device is associated with a higher risk of breast cancer than with non-use.<span class="mw-ref" id="cite_ref-pmid31990981_42-0"><a href="#cite_note-pmid31990981-42" style="counter-reset: mw-Ref 42;"><span class="mw-reflink-text">[42]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Overdose">Overdose</h2></summary>
    
<p>Overdose of levonorgestrel as an emergency contraceptive has not been described.<span class="mw-ref" id="cite_ref-PlanB_One-Step-Label_39-1"><a href="#cite_note-PlanB_One-Step-Label-39" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span> Nausea and vomiting might be expected.<span class="mw-ref" id="cite_ref-PlanB_One-Step-Label_39-2"><a href="#cite_note-PlanB_One-Step-Label-39" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Interactions">Interactions</h2></summary>
    

<p>If taken together with drugs that induce the CYP3A4 cytochrome P450 liver enzyme, levonorgestrel may be metabolized faster and may have lower effectiveness.<span class="mw-ref" id="cite_ref-43"><a href="#cite_note-43" style="counter-reset: mw-Ref 43;"><span class="mw-reflink-text">[43]</span></a></span> 
These include, but are not limited to  barbiturates, bosentan, carbamazepine, felbamate, griseofulvin, oxcarbazepine, phenytoin, rifampin, St. John's wort and topiramate.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacology">Pharmacology</h2></summary>
    
<p>Levonorgestrel (LNG) is a progestin and has effects similar to those of the hormone <a href="Progesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Progesterone" title="Progesterone">progesterone</a>.<span class="mw-ref" id="cite_ref-AHFS2015_5-10"><a href="#cite_note-AHFS2015-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> It works primarily by preventing ovulation and closing off the cervix to prevent the passage of sperm.<span class="mw-ref" id="cite_ref-AHFS2015_5-11"><a href="#cite_note-AHFS2015-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacodynamics">Pharmacodynamics</h3></summary>
    
<p>Levonorgestrel is a progestogen; that is, an agonist of the progesterone receptor (PR), the main biological target of the progestogen sex hormone <a href="Progesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Progesterone" title="Progesterone">progesterone</a>.<span class="mw-ref" id="cite_ref-pmid16112947_2-5"><a href="#cite_note-pmid16112947-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> It is also a weak agonist of the androgen receptor (AR), the main biological target of the androgen sex hormone <a href="Testosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Testosterone" title="Testosterone">testosterone</a>.<span class="mw-ref" id="cite_ref-pmid16112947_2-6"><a href="#cite_note-pmid16112947-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Levonorgestrel has no other important hormonal activity, including no estrogenic, glucocorticoid, or antimineralocorticoid activity.<span class="mw-ref" id="cite_ref-pmid16112947_2-7"><a href="#cite_note-pmid16112947-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> The lack of significant mineralocorticoid or antimineralocorticoid activity with levonorgestrel is in spite of a relatively high affinity for the mineralocorticoid receptor of as much as 75% of that of <a href="Aldosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Aldosterone" title="Aldosterone">aldosterone</a>.<span class="mw-ref" id="cite_ref-pmid16112947_2-8"><a href="#cite_note-pmid16112947-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Due to its progestogenic activity, levonorgestrel has antigonadotropic effects, and is able to suppress fertility and gonadal sex hormone production in both women and men.<span class="mw-ref" id="cite_ref-pmid16112947_2-9"><a href="#cite_note-pmid16112947-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-pmid20933120_44-0"><a href="#cite_note-pmid20933120-44" style="counter-reset: mw-Ref 44;"><span class="mw-reflink-text">[44]</span></a></span></p>

<span>
</span><table class="wikitable sortable mw-collapsible mw-collapsed" style="text-align:left; margin-left:auto; margin-right:auto; border:none;">
<caption class="nowrap"> Relative affinities (%) of levonorgestrel and metabolites</caption>
<tbody><tr>
<th>Compound</th><th><abbr>PR</abbr></th><th><abbr>AR</abbr></th><th><abbr>ER</abbr></th><th><abbr>GR</abbr></th><th><abbr>MR</abbr></th><th><abbr>SHBG</abbr></th><th><abbr>CBG</abbr></th></tr>
<tr>
<td>Levonorgestrel</td><td>150–162</td><td>34<sup>a</sup>, 45</td><td>0</td><td>1–8</td><td>17–75</td><td>50</td><td>0</td></tr>
<tr>
<td>5α-Dihydrolevonorgestrel</td><td>50</td><td>38<sup>a</sup></td><td>0</td><td>?</td><td>?</td><td>?</td><td>?</td></tr>
<tr>
<td>3α,5α-Tetrahydrolevonorgestrel</td><td>?</td><td>?</td><td>0.4</td><td>?</td><td>?</td><td>?</td><td>?</td></tr>
<tr>
<td>3β,5α-Tetrahydrolevonorgestrel</td><td>?</td><td>?</td><td>2.4</td><td>?</td><td>?</td><td>?</td><td>?</td></tr>
<tr class="sortbottom">
<td colspan="8" style="width: 1px; background-color:#eaecf0; text-align: center;"><b>Notes:</b> Values are percentages (%). Reference ligands (100%) were <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Promegestone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Promegestone'" tppabs="https://ptable.com/wiki/compounds/A/Promegestone" title="Promegestone">promegestone</a> for the <abbr>PR</abbr>, <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Metribolone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Metribolone'" tppabs="https://ptable.com/wiki/compounds/A/Metribolone" title="Metribolone">metribolone</a> (<sup>a</sup> = mibolerone) for the <abbr>AR</abbr>, <abbr>E2</abbr> for the <abbr>ER</abbr>, <a href="Dexamethasone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dexamethasone" title="Dexamethasone"><abbr>DEXA</abbr></a> for the <abbr>GR</abbr>, <a href="Aldosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Aldosterone" title="Aldosterone">aldosterone</a> for the <abbr>MR</abbr>, <a href="Dihydrotestosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydrotestosterone" title="Dihydrotestosterone"><abbr>DHT</abbr></a> for <abbr>SHBG</abbr>, and cortisol for <abbr>CBG</abbr>. <b>Sources:</b> See template.</td></tr>
</tbody></table>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Androgenic_activity">Androgenic activity</h4></summary>
    
<p>Levonorgestrel is a weakly androgenic progestin and in women may cause androgenic side effects such as decreased sex hormone-binding globulin (SHBG) levels, decreased <abbr>HDL</abbr> cholesterol levels, weight gain, and acne.<span class="mw-ref" id="cite_ref-pmid16112947_2-10"><a href="#cite_note-pmid16112947-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-pmid7825629_45-0"><a href="#cite_note-pmid7825629-45" style="counter-reset: mw-Ref 45;"><span class="mw-reflink-text">[45]</span></a></span> In combination with a potent estrogen like ethinylestradiol however, all contraceptives containing androgenic progestins are negligibly androgenic in clinical practice and can in fact be used to treat androgen-dependent conditions like acne and hirsutism in women.<span class="mw-ref" id="cite_ref-pmid7825629_45-1"><a href="#cite_note-pmid7825629-45" style="counter-reset: mw-Ref 45;"><span class="mw-reflink-text">[45]</span></a></span> This is because ethinylestradiol causes a marked increase in SHBG levels and thereby decreases levels of free and hence bioactive testosterone, acting as a functional antiandrogen.<span class="mw-ref" id="cite_ref-pmid7825629_45-2"><a href="#cite_note-pmid7825629-45" style="counter-reset: mw-Ref 45;"><span class="mw-reflink-text">[45]</span></a></span> Nonetheless, contraceptives containing progestins that are less androgenic increase SHBG levels to a greater relative extent and may be more effective for such indications.<span class="mw-ref" id="cite_ref-pmid7825629_45-3"><a href="#cite_note-pmid7825629-45" style="counter-reset: mw-Ref 45;"><span class="mw-reflink-text">[45]</span></a></span> Levonorgestrel is currently the most androgenic progestin that remains used in contraceptives, and contraceptives containing levonorgestrel may be less effective for androgen-dependent conditions relative to those containing other progestins that are less androgenic.<span class="mw-ref" id="cite_ref-KnausIsaacs2012_46-0"><a href="#cite_note-KnausIsaacs2012-46" style="counter-reset: mw-Ref 46;"><span class="mw-reflink-text">[46]</span></a></span><span class="mw-ref" id="cite_ref-GolanTashjian2011_47-0"><a href="#cite_note-GolanTashjian2011-47" style="counter-reset: mw-Ref 47;"><span class="mw-reflink-text">[47]</span></a></span><span class="mw-ref" id="cite_ref-BreastCancer1991_48-0"><a href="#cite_note-BreastCancer1991-48" style="counter-reset: mw-Ref 48;"><span class="mw-reflink-text">[48]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Other_activity">Other activity</h4></summary>
    
<p>Levonorgestrel stimulates the proliferation of MCF-7 breast cancer cells <i>in vitro</i>, an action that is independent of the classical PRs and is instead mediated via the progesterone receptor membrane component-1 (PGRMC1).<span class="mw-ref" id="cite_ref-pmid23758160_49-0"><a href="#cite_note-pmid23758160-49" style="counter-reset: mw-Ref 49;"><span class="mw-reflink-text">[49]</span></a></span><span class="mw-ref" id="cite_ref-pmid22335423_50-0"><a href="#cite_note-pmid22335423-50" style="counter-reset: mw-Ref 50;"><span class="mw-reflink-text">[50]</span></a></span> Certain other progestins act similarly in this assay, whereas progesterone acts neutrally.<span class="mw-ref" id="cite_ref-pmid23758160_49-1"><a href="#cite_note-pmid23758160-49" style="counter-reset: mw-Ref 49;"><span class="mw-reflink-text">[49]</span></a></span><span class="mw-ref" id="cite_ref-pmid22335423_50-1"><a href="#cite_note-pmid22335423-50" style="counter-reset: mw-Ref 50;"><span class="mw-reflink-text">[50]</span></a></span> It is unclear if these findings may explain the different risks of breast cancer observed with progesterone and progestins in clinical studies.<span class="mw-ref" id="cite_ref-pmid31512725_51-0"><a href="#cite_note-pmid31512725-51" style="counter-reset: mw-Ref 51;"><span class="mw-reflink-text">[51]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Antigonadotropic_effects">Antigonadotropic effects</h4></summary>
    
<p>In men, levonorgestrel causes marked suppression of circulating testosterone levels secondary to its antigonadotropic effects.<span class="mw-ref" id="cite_ref-pmid12826683_52-0"><a href="#cite_note-pmid12826683-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span> Because of this, and due to its androgenic activity being only weak and hence insufficient for purposes of androgen replacement in males, levonorgestrel has potent functional antiandrogenic effects in men, and is able to produce associated adverse effects like decreased libido and erectile dysfunction among others.<span class="mw-ref" id="cite_ref-pmid12826683_52-1"><a href="#cite_note-pmid12826683-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span> In relation to this, levonorgestrel has been combined with an androgen like testosterone or dihydrotestosterone when it has been studied as a hormonal contraceptive in men.<span class="mw-ref" id="cite_ref-pmid20933120_44-1"><a href="#cite_note-pmid20933120-44" style="counter-reset: mw-Ref 44;"><span class="mw-reflink-text">[44]</span></a></span><span class="mw-ref" id="cite_ref-pmid12826683_52-2"><a href="#cite_note-pmid12826683-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacokinetics">Pharmacokinetics</h3></summary>
    
<p>The bioavailability of levonorgestrel is approximately 95% (range 85 to 100%).<span class="mw-ref" id="cite_ref-pmid16112947_2-11"><a href="#cite_note-pmid16112947-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-pmid8842581_3-1"><a href="#cite_note-pmid8842581-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> The plasma protein binding of levonorgestrel is about 98%.<span class="mw-ref" id="cite_ref-pmid16112947_2-12"><a href="#cite_note-pmid16112947-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> It is bound 50% to <a href="Human_serum_albumin.htm" tppabs="https://ptable.com/wiki/compounds/A/Human_serum_albumin" title="Human serum albumin">albumin</a> and 48% to SHBG.<span class="mw-ref" id="cite_ref-pmid16112947_2-13"><a href="#cite_note-pmid16112947-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Levonorgestrel is metabolized in the liver, via reduction, hydroxylation, and conjugation (specifically glucuronidation and sulfation).<span class="mw-ref" id="cite_ref-pmid16112947_2-14"><a href="#cite_note-pmid16112947-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-ShoupeHaseltine2012_4-2"><a href="#cite_note-ShoupeHaseltine2012-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> Oxidation occurs primarily at the C2α and C16β positions, while reduction occurs in the A ring.<span class="mw-ref" id="cite_ref-ShoupeHaseltine2012_4-3"><a href="#cite_note-ShoupeHaseltine2012-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> 5α-Dihydrolevonorgestrel is produced as an active metabolite of levonorgestrel by 5α-reductase.<span class="mw-ref" id="cite_ref-pmid16112947_2-15"><a href="#cite_note-pmid16112947-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> The elimination half-life of levonorgestrel is 24 to 32<span>&nbsp;</span>hours, although values as short as 8<span>&nbsp;</span>hours and as great as 45<span>&nbsp;</span>hours have been reported.<span class="mw-ref" id="cite_ref-pmid16112947_2-16"><a href="#cite_note-pmid16112947-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-ShoupeHaseltine2012_4-4"><a href="#cite_note-ShoupeHaseltine2012-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> About 20 to 67% of a single oral dose of levonorgestrel is eliminated in urine and 21 to 34% in feces.<span class="mw-ref" id="cite_ref-ShoupeHaseltine2012_4-5"><a href="#cite_note-ShoupeHaseltine2012-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Chemistry">Chemistry</h2></summary>
    
<div role="note" class="hatnote navigation-not-searchable">See also: List of progestogens, List of androgens/anabolic steroids, and <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Norgestrel  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Norgestrel'" tppabs="https://ptable.com/wiki/compounds/A/Norgestrel" title="Norgestrel">Norgestrel</a></div>

<p>Levonorgestrel, also known as 17α-ethynyl-18-methyl-19-nortestosterone or as 17α-ethynyl-18-methylestr-4-en-17β-ol-3-one, is a synthetic estrane steroid and a derivative of <a href="Testosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Testosterone" title="Testosterone">testosterone</a>.<span class="mw-ref" id="cite_ref-Elks2014_53-0"><a href="#cite_note-Elks2014-53" style="counter-reset: mw-Ref 53;"><span class="mw-reflink-text">[53]</span></a></span><span class="mw-ref" id="cite_ref-IndexNominum2000_54-0"><a href="#cite_note-IndexNominum2000-54" style="counter-reset: mw-Ref 54;"><span class="mw-reflink-text">[54]</span></a></span> It is the C13β or levorotatory stereoisomer and enantiopure form of <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Norgestrel  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Norgestrel'" tppabs="https://ptable.com/wiki/compounds/A/Norgestrel" title="Norgestrel">norgestrel</a>, the C13α or dextrorotatory isomer being inactive.<span class="mw-ref" id="cite_ref-AlldredgeCorelli2012_55-0"><a href="#cite_note-AlldredgeCorelli2012-55" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span><span class="mw-ref" id="cite_ref-LaverySanfilippo2012_56-0"><a href="#cite_note-LaverySanfilippo2012-56" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span> Levonorgestrel is more specifically a derivative of <a href="Norethisterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Norethisterone" title="Norethisterone">norethisterone</a> (17α-ethynyl-19-nortestosterone) and is the parent compound of the gonane (18-methylestrane) subgroup of the <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Nandrolone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Nandrolone'" tppabs="https://ptable.com/wiki/compounds/A/19-nortestosterone" title="19-nortestosterone" class="mw-redirect">19-nortestosterone</a> family of progestins.<span class="mw-ref" id="cite_ref-OffermannsRosenthal2008_57-0"><a href="#cite_note-OffermannsRosenthal2008-57" style="counter-reset: mw-Ref 57;"><span class="mw-reflink-text">[57]</span></a></span> Levonorgestrel acetate and levonorgestrel butanoate are C17β esters of levonorgestrel.<span class="mw-ref" id="cite_ref-GWU1987_58-0"><a href="#cite_note-GWU1987-58" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span><span class="mw-ref" id="cite_ref-pmid6658872_59-0"><a href="#cite_note-pmid6658872-59" style="counter-reset: mw-Ref 59;"><span class="mw-reflink-text">[59]</span></a></span> It has a molecular weight of 312.45<span>&nbsp;</span>g/mol and a partition coefficient (logP) of 3.8.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    
<p><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Norgestrel  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Norgestrel'" tppabs="https://ptable.com/wiki/compounds/A/Norgestrel" title="Norgestrel">Norgestrel</a> (<i>rac</i>-13-ethyl-17α-ethynyl-19-nortestosterone), the racemic mixture containing levonorgestrel and <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Norgestrel  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Norgestrel'" tppabs="https://ptable.com/wiki/compounds/A/Dextronorgestrel" title="Dextronorgestrel" class="mw-redirect">dextronorgestrel</a>, was discovered by Hughes and colleagues at Wyeth in 1963 via structural modification of <a href="Norethisterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Norethisterone" title="Norethisterone">norethisterone</a> (17α-ethynyl-19-nortestosterone).<span class="mw-ref" id="cite_ref-Meikle1999_60-0"><a href="#cite_note-Meikle1999-60" style="counter-reset: mw-Ref 60;"><span class="mw-reflink-text">[60]</span></a></span><span class="mw-ref" id="cite_ref-SzejtliSzente2012_61-0"><a href="#cite_note-SzejtliSzente2012-61" style="counter-reset: mw-Ref 61;"><span class="mw-reflink-text">[61]</span></a></span><span class="mw-ref" id="cite_ref-FilshieGuillebaud2013_62-0"><a href="#cite_note-FilshieGuillebaud2013-62" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span><span class="mw-ref" id="cite_ref-Marks2010_63-0"><a href="#cite_note-Marks2010-63" style="counter-reset: mw-Ref 63;"><span class="mw-reflink-text">[63]</span></a></span> It was the first progestogen to be manufactured via total chemical synthesis.<span class="mw-ref" id="cite_ref-FilshieGuillebaud2013_62-1"><a href="#cite_note-FilshieGuillebaud2013-62" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span><span class="mw-ref" id="cite_ref-Marks2010_63-1"><a href="#cite_note-Marks2010-63" style="counter-reset: mw-Ref 63;"><span class="mw-reflink-text">[63]</span></a></span> Norgestrel was introduced for medical use as a combined birth control pill with ethinylestradiol under the brand name <i>Eugynon</i> in Germany in 1966 and under the brand name <i>Ovral</i> in the United States 1968, and as a <a href="Progestogen-only_pill.htm" tppabs="https://ptable.com/wiki/compounds/A/Progestogen-only_pill" title="Progestogen-only pill">progestogen-only pill</a> under the brand name <i>Ovrette</i> in the United States in 1973.<span class="mw-ref" id="cite_ref-Marks2010_63-2"><a href="#cite_note-Marks2010-63" style="counter-reset: mw-Ref 63;"><span class="mw-reflink-text">[63]</span></a></span><span class="mw-ref" id="cite_ref-Pohl2004_64-0"><a href="#cite_note-Pohl2004-64" style="counter-reset: mw-Ref 64;"><span class="mw-reflink-text">[64]</span></a></span><span class="mw-ref" id="cite_ref-Ortiz-GómezSantesmases2016_65-0"><a href="#cite_note-Ortiz-GómezSantesmases2016-65" style="counter-reset: mw-Ref 65;"><span class="mw-reflink-text">[65]</span></a></span><span class="mw-ref" id="cite_ref-ToneWatkins2007_66-0"><a href="#cite_note-ToneWatkins2007-66" style="counter-reset: mw-Ref 66;"><span class="mw-reflink-text">[66]</span></a></span> Following its discovery, norgestrel had been licensed by Wyeth to Schering AG, which separated the racemic mixture into its two optical isomers and identified levonorgestrel (13β-ethyl-17α-ethynyl-19-nortestosterone) as the active component of the mixture.<span class="mw-ref" id="cite_ref-Roth2014_10-1"><a href="#cite_note-Roth2014-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span><span class="mw-ref" id="cite_ref-FilshieGuillebaud2013_62-2"><a href="#cite_note-FilshieGuillebaud2013-62" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span><span class="mw-ref" id="cite_ref-Marks2010_63-3"><a href="#cite_note-Marks2010-63" style="counter-reset: mw-Ref 63;"><span class="mw-reflink-text">[63]</span></a></span> Levonorgestrel was first studied in humans by 1970, and was introduced for medical use in Germany as a combined birth control pill with ethinylestradiol under the brand name <i>Neogynon</i> in August 1970.<span class="mw-ref" id="cite_ref-Roth2014_10-2"><a href="#cite_note-Roth2014-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span><span class="mw-ref" id="cite_ref-Pohl2004_64-1"><a href="#cite_note-Pohl2004-64" style="counter-reset: mw-Ref 64;"><span class="mw-reflink-text">[64]</span></a></span><span class="mw-ref" id="cite_ref-Ortiz-GómezSantesmases2016_65-1"><a href="#cite_note-Ortiz-GómezSantesmases2016-65" style="counter-reset: mw-Ref 65;"><span class="mw-reflink-text">[65]</span></a></span><span class="mw-ref" id="cite_ref-Albach1993_67-0"><a href="#cite_note-Albach1993-67" style="counter-reset: mw-Ref 67;"><span class="mw-reflink-text">[67]</span></a></span><span class="mw-ref" id="cite_ref-ApeloVeloso1970_68-0"><a href="#cite_note-ApeloVeloso1970-68" style="counter-reset: mw-Ref 68;"><span class="mw-reflink-text">[68]</span></a></span><span class="mw-ref" id="cite_ref-BrosensVanAssche1971_69-0"><a href="#cite_note-BrosensVanAssche1971-69" style="counter-reset: mw-Ref 69;"><span class="mw-reflink-text">[69]</span></a></span> A more widely used formulation, containing lower doses of ethinylestradiol and levonorgestrel, was introduced under the brand name <i>Microgynon</i> by 1973.<span class="mw-ref" id="cite_ref-Drugs.com_15-8"><a href="#cite_note-Drugs.com-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span><span class="mw-ref" id="cite_ref-SchneiderSpona1974_70-0"><a href="#cite_note-SchneiderSpona1974-70" style="counter-reset: mw-Ref 70;"><span class="mw-reflink-text">[70]</span></a></span><span class="mw-ref" id="cite_ref-pmid4614952_71-0"><a href="#cite_note-pmid4614952-71" style="counter-reset: mw-Ref 71;"><span class="mw-reflink-text">[71]</span></a></span> In addition to combined formulations, levonorgestrel was introduced as a progestogen-only pill under the brand names <i>Microlut</i> by 1972 and <i>Microval</i> by 1974.<span class="mw-ref" id="cite_ref-Scharff1972_72-0"><a href="#cite_note-Scharff1972-72" style="counter-reset: mw-Ref 72;"><span class="mw-reflink-text">[72]</span></a></span><span class="mw-ref" id="cite_ref-pmid4817042_73-0"><a href="#cite_note-pmid4817042-73" style="counter-reset: mw-Ref 73;"><span class="mw-reflink-text">[73]</span></a></span> Many other formulations and brand names of levonorgestrel-containing birth control pills have also been marketed.<span class="mw-ref" id="cite_ref-Drugs.com_15-9"><a href="#cite_note-Drugs.com-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></p>

<p>Levonorgestrel, taken alone in a single high dose, was first evaluated as a form of emergency contraception in 1973.<span class="mw-ref" id="cite_ref-KesserüLarrañaga1973_74-0"><a href="#cite_note-KesserüLarrañaga1973-74" style="counter-reset: mw-Ref 74;"><span class="mw-reflink-text">[74]</span></a></span> It was the second progestin to be evaluated for such purposes, following a study of quingestanol acetate in 1970.<span class="mw-ref" id="cite_ref-KesserüLarrañaga1973_74-1"><a href="#cite_note-KesserüLarrañaga1973-74" style="counter-reset: mw-Ref 74;"><span class="mw-reflink-text">[74]</span></a></span><span class="mw-ref" id="cite_ref-RubioBerman1970_75-0"><a href="#cite_note-RubioBerman1970-75" style="counter-reset: mw-Ref 75;"><span class="mw-reflink-text">[75]</span></a></span> In 1974, the Yuzpe regimen, which consisted of high doses of a combined birth control pill containing ethinylestradiol and norgestrel, was described as a method of emergency contraception by A. Albert Yuzpe and colleagues, and saw widespread interest.<span class="mw-ref" id="cite_ref-Balaji2009_76-0"><a href="#cite_note-Balaji2009-76" style="counter-reset: mw-Ref 76;"><span class="mw-reflink-text">[76]</span></a></span><span class="mw-ref" id="cite_ref-pmid4844513_77-0"><a href="#cite_note-pmid4844513-77" style="counter-reset: mw-Ref 77;"><span class="mw-reflink-text">[77]</span></a></span> Levonorgestrel-only emergency contraception was introduced under the brand name <i>Postinor</i> by 1978.<span class="mw-ref" id="cite_ref-Farkas1978_78-0"><a href="#cite_note-Farkas1978-78" style="counter-reset: mw-Ref 78;"><span class="mw-reflink-text">[78]</span></a></span> Ho and Kwan published the first study comparing levonorgestrel only and the Yuzpe regimen as methods of emergency contraception in 1993 and found that they had similar effectiveness but that levonorgestrel alone was better-tolerated.<span class="mw-ref" id="cite_ref-ArtiniGenazzani2001_79-0"><a href="#cite_note-ArtiniGenazzani2001-79" style="counter-reset: mw-Ref 79;"><span class="mw-reflink-text">[79]</span></a></span><span class="mw-ref" id="cite_ref-pmid8473453_80-0"><a href="#cite_note-pmid8473453-80" style="counter-reset: mw-Ref 80;"><span class="mw-reflink-text">[80]</span></a></span> In relation to this, the Yuzpe regimen has largely been replaced as a method of emergency contraception by levonorgrestrel-only preparations.<span class="mw-ref" id="cite_ref-King2013_81-0"><a href="#cite_note-King2013-81" style="counter-reset: mw-Ref 81;"><span class="mw-reflink-text">[81]</span></a></span> Levonorgestrel-only emergency contraception was approved in the United States under the brand name <i>Plan B</i> in 1999, and has also been marketed widely elsewhere throughout the world under other brand names such as <i>Levonelle</i> and <i>NorLevo</i> in addition to <i>Postinor</i>.<span class="mw-ref" id="cite_ref-Drugs.com_15-10"><a href="#cite_note-Drugs.com-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span><span class="mw-ref" id="cite_ref-Harrison-Woolrych2015_82-0"><a href="#cite_note-Harrison-Woolrych2015-82" style="counter-reset: mw-Ref 82;"><span class="mw-reflink-text">[82]</span></a></span> In 2013, the Food and Drug Administration approved <i>Plan B One-Step</i> for sale over-the-counter in the United States without a prescription or age restriction.<span class="mw-ref" id="cite_ref-CBSNews2013_83-0"><a href="#cite_note-CBSNews2013-83" style="counter-reset: mw-Ref 83;"><span class="mw-reflink-text">[83]</span></a></span></p>

<p>Levonorgestrel has also been introduced for use as a progestogen-only intrauterine device under the brand names <i>Mirena</i> and <i>Skyla</i> among others, as a progestogen-only birth control implant under the brand names <i>Norplant</i> and <i>Jadelle</i>, as a combined oral tablet with estradiol valerate for menopausal hormone therapy under the brand name <i>Klimonorm</i>, and as a combined transdermal patch with estradiol for menopausal hormone therapy under the brand name <i>Climara Pro</i>.<span class="mw-ref" id="cite_ref-Drugs.com_15-11"><a href="#cite_note-Drugs.com-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span><span class="mw-ref" id="cite_ref-pmid26732558_16-2"><a href="#cite_note-pmid26732558-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span><span class="mw-ref" id="cite_ref-Kubíková2014_30-2"><a href="#cite_note-Kubíková2014-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span> Ester prodrugs of levonorgestrel such as levonorgestrel acetate and levonorgestrel butanoate have been developed and studied as other forms of birth control such as long-acting progestogen-only injectable contraceptives and contraceptive vaginal rings, but have not been marketed for medical use.<span class="mw-ref" id="cite_ref-GWU1987_58-1"><a href="#cite_note-GWU1987-58" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span><span class="mw-ref" id="cite_ref-pmid6658872_59-1"><a href="#cite_note-pmid6658872-59" style="counter-reset: mw-Ref 59;"><span class="mw-reflink-text">[59]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Society_and_culture">Society and culture</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Generic_names">Generic names</h3></summary>
    
<p><i>Levonorgestrel</i> is the generic name of the drug and its <abbr>INN</abbr>, <abbr>USAN</abbr>, <abbr>USP</abbr>, <abbr>BAN</abbr>, <abbr>DCIT</abbr>, and <abbr>JAN</abbr>, while <i>lévonorgestrel</i> is its <abbr>DCF</abbr>.<span class="mw-ref" id="cite_ref-Drugs.com_15-12"><a href="#cite_note-Drugs.com-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span><span class="mw-ref" id="cite_ref-Elks2014_53-1"><a href="#cite_note-Elks2014-53" style="counter-reset: mw-Ref 53;"><span class="mw-reflink-text">[53]</span></a></span><span class="mw-ref" id="cite_ref-IndexNominum2000_54-1"><a href="#cite_note-IndexNominum2000-54" style="counter-reset: mw-Ref 54;"><span class="mw-reflink-text">[54]</span></a></span> It is also known as <i>d-norgestrel</i>, <i>d(–)-norgestrel</i>, or <i><small>D</small>-norgestrel</i>, as well as by its developmental code names <i>WY-5104</i> (Wyeth) and <i>SH-90999</i> (Schering AG).<span class="mw-ref" id="cite_ref-Drugs.com_15-13"><a href="#cite_note-Drugs.com-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span><span class="mw-ref" id="cite_ref-Elks2014_53-2"><a href="#cite_note-Elks2014-53" style="counter-reset: mw-Ref 53;"><span class="mw-reflink-text">[53]</span></a></span><span class="mw-ref" id="cite_ref-IndexNominum2000_54-2"><a href="#cite_note-IndexNominum2000-54" style="counter-reset: mw-Ref 54;"><span class="mw-reflink-text">[54]</span></a></span><span class="mw-ref" id="cite_ref-Scharff1972_72-1"><a href="#cite_note-Scharff1972-72" style="counter-reset: mw-Ref 72;"><span class="mw-reflink-text">[72]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Brand_names">Brand names</h3></summary>
    
<p>Levonorgestrel is marketed alone or in combination with an <a href="Estrogen.htm" tppabs="https://ptable.com/wiki/compounds/A/Estrogen" title="Estrogen">estrogen</a> (specifically ethinylestradiol, <a href="Estradiol.htm" tppabs="https://ptable.com/wiki/compounds/A/Estradiol" title="Estradiol">estradiol</a>, or estradiol valerate) under a multitude of brand names throughout the world, including <i>Alesse</i>, Altavera, Alysena, Amethia, Amethyst, Ashlyna, Aviane, Camrese, Chateal, <i>Climara Pro</i>, <i>Cycle 21</i>, Daysee, Emerres, Enpresse, Erlibelle, <i>Escapelle</i>, Falmina, Introvale, Isteranda, <i>Jadelle</i>, <i>Jaydess</i>, Jolessa, <i>Klimonorm</i>, Kurvelo, Kyleena, Lessina, <i>Levlen</i>, Levodonna, <i>Levonelle</i>, Levonest, Levosert, Levora, Liletta, <i>Loette</i>, <i>Logynon</i>, <i>LoSeasonique</i>, Lutera, Lybrel, Marlissa, <i>Microgynon</i>, <i>Microlut</i>, <i>Microvlar</i>, Min-Ovral, <i>Miranova</i>, <i>Mirena</i>, My Way, Myzilra, Next Choice, <i>Nordette</i>, Norgeston, NorLevo, <i>Norplant</i> ,One Pill, Option 2, Orsythia, Ovima, Ovranette, <i>Plan B</i>, <i>Plan B One-Step</i>, Portia, <i>Postinor</i>, <i>Postinor-2</i>, Preventeza, Ramonna, <i>Rigevidon</i>, Quartette, Quasense, <i>Seasonale</i>, <i>Seasonique</i>, <i>Skyla</i>, Sronyx, Tri-Levlen, <i>Trinordiol</i>, Triphasil, <i>Triquilar</i>, <i>Tri-Regol</i>, Trivora, and Upostelle, among many others.<span class="mw-ref" id="cite_ref-Drugs.com_15-14"><a href="#cite_note-Drugs.com-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span><span class="mw-ref" id="cite_ref-IndexNominum2000_54-3"><a href="#cite_note-IndexNominum2000-54" style="counter-reset: mw-Ref 54;"><span class="mw-reflink-text">[54]</span></a></span><span class="mw-ref" id="cite_ref-Princeton2017_84-0"><a href="#cite_note-Princeton2017-84" style="counter-reset: mw-Ref 84;"><span class="mw-reflink-text">[84]</span></a></span> These formulations are used as emergency contraceptives, normal contraceptives, or in menopausal hormone therapy for the treatment of menopausal symptoms.</p>

<p>As an emergency contraceptive, levonorgestrel is often referred to colloquially as the "morning-after pill".<span class="mw-ref" id="cite_ref-OatsAbraham2011_85-0"><a href="#cite_note-OatsAbraham2011-85" style="counter-reset: mw-Ref 85;"><span class="mw-reflink-text">[85]</span></a></span><span class="mw-ref" id="cite_ref-CarlsonEisenstat2004_86-0"><a href="#cite_note-CarlsonEisenstat2004-86" style="counter-reset: mw-Ref 86;"><span class="mw-reflink-text">[86]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Availability">Availability</h3></summary>
    


<p>Levonorgestrel is very widely marketed throughout the world and is available in almost every country.<span class="mw-ref" id="cite_ref-Drugs.com_15-15"><a href="#cite_note-Drugs.com-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span><span class="mw-ref" id="cite_ref-IndexNominum2000_54-4"><a href="#cite_note-IndexNominum2000-54" style="counter-reset: mw-Ref 54;"><span class="mw-reflink-text">[54]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Accessibility">Accessibility</h3></summary>
    
<p>Levonorgestrel-containing emergency contraception is available over-the-counter in some countries, such as the United States.<span class="mw-ref" id="cite_ref-CBSNews2013_83-1"><a href="#cite_note-CBSNews2013-83" style="counter-reset: mw-Ref 83;"><span class="mw-reflink-text">[83]</span></a></span></p>

<p>A policy update in 2015, required all Indian Health Services-run pharmacies, clinics, and emergency departments to have Plan B One-Step in stock, to distribute it to any woman (or her representative) who asked for it without a prescription, age verification, registration or any other requirement, to provide orientation training to all staff regarding the medication, to provide unbiased and medically accurate information about emergency contraception, and to make someone available at all times to distribute the pill in case the primary staffer objected to providing it on religious or moral grounds.<span class="mw-ref" id="cite_ref-87"><a href="#cite_note-87" style="counter-reset: mw-Ref 87;"><span class="mw-reflink-text">[87]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Research">Research</h2></summary>
    
<p>Levonorgestrel has been studied in combination with androgens such as testosterone and dihydrotestosterone as a hormonal contraceptive for men.<span class="mw-ref" id="cite_ref-pmid20933120_44-2"><a href="#cite_note-pmid20933120-44" style="counter-reset: mw-Ref 44;"><span class="mw-reflink-text">[44]</span></a></span><span class="mw-ref" id="cite_ref-pmid12826683_52-3"><a href="#cite_note-pmid12826683-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references"><li id="cite_note-Drugs.com_pregnancy-1"> <span id="mw-reference-text-cite_note-Drugs.com_pregnancy-1" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/pregnancy/levonorgestrel.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/pregnancy/levonorgestrel.html'" tppabs="https://www.drugs.com/pregnancy/levonorgestrel.html" class="external text external">"Levonorgestrel Use During Pregnancy"</a>. <i>Drugs.com</i>. 23 March 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">29 June</span> 2020</span>.</cite></span></li><li id="cite_note-pmid16112947-2"> <span id="mw-reference-text-cite_note-pmid16112947-2" class="mw-reference-text"><cite id="CITEREFKuhl2005" class="citation journal cs1">Kuhl H (August 2005). "Pharmacology of estrogens and progestogens: influence of different routes of administration". <i>Climacteric</i>. 8 Suppl 1: 3–63. doi:<a href="javascript:if(confirm('https://doi.org/10.1080%2F13697130500148875  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1080%2F13697130500148875'" tppabs="https://doi.org/10.1080%2F13697130500148875" class="external text external">10.1080/13697130500148875</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16112947  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16112947'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16112947" class="external text external">16112947</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:24616324  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:24616324'" tppabs="https://api.semanticscholar.org/CorpusID:24616324" class="external text external">24616324</a>.</cite></span></li><li id="cite_note-pmid8842581-3"> <span id="mw-reference-text-cite_note-pmid8842581-3" class="mw-reference-text"><cite id="CITEREFFotherby1996" class="citation journal cs1">Fotherby K (August 1996). "Bioavailability of orally administered sex steroids used in oral contraception and hormone replacement therapy". <i>Contraception</i>. <b>54</b> (2): 59–69. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0010-7824%2896%2900136-9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0010-7824%2896%2900136-9'" tppabs="https://doi.org/10.1016%2F0010-7824%2896%2900136-9" class="external text external">10.1016/0010-7824(96)00136-9</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8842581  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8842581'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8842581" class="external text external">8842581</a>.</cite></span></li><li id="cite_note-ShoupeHaseltine2012-4"> <span id="mw-reference-text-cite_note-ShoupeHaseltine2012-4" class="mw-reference-text"><cite id="CITEREFShoupeHaseltine2012" class="citation book cs1">Shoupe D, Haseltine FP (6 December 2012). <a href="javascript:if(confirm('https://books.google.com/books?id=cpDhBwAAQBAJ&pg=PA22  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=cpDhBwAAQBAJ&pg=PA22'" tppabs="https://books.google.com/books?id=cpDhBwAAQBAJ&pg=PA22" class="external text external"><i>Contraception</i></a>. Springer Science &amp; Business Media. pp.<span>&nbsp;</span>22–. ISBN<span>&nbsp;</span><bdi>978-1-4612-2730-4</bdi>.</cite></span></li><li id="cite_note-AHFS2015-5"> <span id="mw-reference-text-cite_note-AHFS2015-5" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/monograph/progestins-etonogestrel-levonorgestrel-norethindrone.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/progestins-etonogestrel-levonorgestrel-norethindrone.html'" tppabs="https://www.drugs.com/monograph/progestins-etonogestrel-levonorgestrel-norethindrone.html" class="external text external">"Progestins (Etonogestrel, Levonorgestrel, Norethindrone)"</a>. The American Society of Health-System Pharmacists. <a href="javascript:if(confirm('https://web.archive.org/web/20150907223756/http://www.drugs.com/monograph/progestins-etonogestrel-levonorgestrel-norethindrone.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20150907223756/http://www.drugs.com/monograph/progestins-etonogestrel-levonorgestrel-norethindrone.html'" tppabs="https://web.archive.org/web/20150907223756/http://www.drugs.com/monograph/progestins-etonogestrel-levonorgestrel-norethindrone.html" class="external text external">Archived</a> from the original on 2015-09-07<span class="reference-accessdate">. Retrieved <span class="nowrap">Aug 21,</span> 2015</span>.</cite></span></li><li id="cite_note-6"> <span id="mw-reference-text-cite_note-6" class="mw-reference-text"><cite class="citation book cs1"><a href="javascript:if(confirm('https://books.google.com/books?id=Kd7lNFPipaIC&pg=PT174  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=Kd7lNFPipaIC&pg=PT174'" tppabs="https://books.google.com/books?id=Kd7lNFPipaIC&pg=PT174" class="external text external"><i>Postgraduate Gynecology</i></a>. Jaypee Brothers Medical Pub. 2011. p.<span>&nbsp;</span>159. ISBN<span>&nbsp;</span><bdi>9789350250822</bdi>. <a href="javascript:if(confirm('https://web.archive.org/web/20150926022813/https://books.google.ca/books?id=Kd7lNFPipaIC&pg=PT174  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20150926022813/https://books.google.ca/books?id=Kd7lNFPipaIC&pg=PT174'" tppabs="https://web.archive.org/web/20150926022813/https://books.google.ca/books?id=Kd7lNFPipaIC&pg=PT174" class="external text external">Archived</a> from the original on 2015-09-26.</cite></span></li><li id="cite_note-Gem2010-7"> <span id="mw-reference-text-cite_note-Gem2010-7" class="mw-reference-text"><cite id="CITEREFGemzell-Danielsson2010" class="citation journal cs1">Gemzell-Danielsson, K (November 2010). "Mechanism of action of emergency contraception". <i>Contraception</i>. <b>82</b> (5): 404–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.contraception.2010.05.004  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.contraception.2010.05.004'" tppabs="https://doi.org/10.1016%2Fj.contraception.2010.05.004" class="external text external">10.1016/j.contraception.2010.05.004</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20933113  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20933113'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20933113" class="external text external">20933113</a>.</cite></span></li><li id="cite_note-8"> <span id="mw-reference-text-cite_note-8" class="mw-reference-text"><cite class="citation book cs1"><a href="javascript:if(confirm('https://books.google.com/books?id=cvKaqyMOGjUC&pg=PT15  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=cvKaqyMOGjUC&pg=PT15'" tppabs="https://books.google.com/books?id=cvKaqyMOGjUC&pg=PT15" class="external text external">"Chapter 1"</a>. <i>Research on reproductive health at WHO<span>&nbsp;</span>: biennial report 2000-2001</i>. Geneva: World health organization. 2002. ISBN<span>&nbsp;</span><bdi>9789241562089</bdi>. <a href="javascript:if(confirm('https://web.archive.org/web/20150926040930/https://books.google.ca/books?id=cvKaqyMOGjUC&pg=PT15  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20150926040930/https://books.google.ca/books?id=cvKaqyMOGjUC&pg=PT15'" tppabs="https://web.archive.org/web/20150926040930/https://books.google.ca/books?id=cvKaqyMOGjUC&pg=PT15" class="external text external">Archived</a> from the original on 2015-09-26.</cite></span></li><li id="cite_note-Fis2006-9"> <span id="mw-reference-text-cite_note-Fis2006-9" class="mw-reference-text"><cite id="CITEREFFischerGanellin2006" class="citation book cs1">Fischer J, Ganellin CR (2006). <a href="javascript:if(confirm('https://books.google.com/books?id=FjKfqkaKkAAC&pg=PA479  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=FjKfqkaKkAAC&pg=PA479'" tppabs="https://books.google.com/books?id=FjKfqkaKkAAC&pg=PA479" class="external text external"><i>Analogue-based Drug Discovery</i></a>. John Wiley &amp; Sons. p.<span>&nbsp;</span>479. ISBN<span>&nbsp;</span><bdi>9783527607495</bdi>.</cite></span></li><li id="cite_note-Roth2014-10"> <span id="mw-reference-text-cite_note-Roth2014-10" class="mw-reference-text"><cite id="CITEREFRoth2014" class="citation book cs1">Roth K (2014). <a href="javascript:if(confirm('https://books.google.com/books?id=FsKpBAAAQBAJ&pg=PA77  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=FsKpBAAAQBAJ&pg=PA77'" tppabs="https://books.google.com/books?id=FsKpBAAAQBAJ&pg=PA77" class="external text external"><i>Chemische Leckerbissen</i></a>. John Wiley &amp; Sons. pp.<span>&nbsp;</span>77–. ISBN<span>&nbsp;</span><bdi>978-3-527-33739-2</bdi>. <q>[Levonorgestrel (24): The product generated by Smith's norgestrel total synthesis was a racemate, so half of each consisted of the left- and the right-handed enantiomer. Chemists at Schering discovered that only the levorotatory enantiomer was effective [49] and developed a biotechnological process for the preparation of the pure levorotatory enantiomer. This was the active ingredient levonorgestrel born. With the single-acting enantiomer, the dose and thus the liver burden could be halved again. The resulting Neogynon® contained 0.25 mg levonorgestrel and 0.05 mg ethinylestradiol and was introduced in 1970.]</q></cite></span></li><li id="cite_note-WHO21st-11"> <span id="mw-reference-text-cite_note-WHO21st-11" class="mw-reference-text"><cite id="CITEREFWorld_Health_Organization2019" class="citation book cs1">World Health Organization (2019). <i>World Health Organization model list of essential medicines: 21st list 2019</i>. Geneva: World Health Organization. hdl:<a href="javascript:if(confirm('https://hdl.handle.net/10665%2F325771  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://hdl.handle.net/10665%2F325771'" tppabs="https://hdl.handle.net/10665%2F325771" class="external text external">10665/325771</a>. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.</cite></span></li><li id="cite_note-Ric2014-12"> <span id="mw-reference-text-cite_note-Ric2014-12" class="mw-reference-text"><cite id="CITEREFHamilton2014" class="citation book cs1">Hamilton RJ (2014). <a href="javascript:if(confirm('https://books.google.com/books?id=BwqEAgAAQBAJ&pg=PA310  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=BwqEAgAAQBAJ&pg=PA310'" tppabs="https://books.google.com/books?id=BwqEAgAAQBAJ&pg=PA310" class="external text external"><i>Tarascon pocket pharmacopoeia<span>&nbsp;</span>: 2014 deluxe lab-pocket edition</i></a> (15th ed.). Sudbury: Jones &amp; Bartlett Learning. pp.<span>&nbsp;</span>310–312. ISBN<span>&nbsp;</span><bdi>9781284053999</bdi>. <a href="javascript:if(confirm('https://web.archive.org/web/20150926022049/https://books.google.ca/books?id=BwqEAgAAQBAJ&pg=PA310  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20150926022049/https://books.google.ca/books?id=BwqEAgAAQBAJ&pg=PA310'" tppabs="https://web.archive.org/web/20150926022049/https://books.google.ca/books?id=BwqEAgAAQBAJ&pg=PA310" class="external text external">Archived</a> from the original on 2015-09-26.</cite></span></li><li id="cite_note-13"> <span id="mw-reference-text-cite_note-13" class="mw-reference-text"><cite class="citation pressrelease cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20160114114254/https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm358082.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20160114114254/https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm358082.htm'" tppabs="https://web.archive.org/web/20160114114254/https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm358082.htm" class="external text external">"FDA approves Plan B One-Step emergency contraceptive for use without a prescription for all women of child-bearing potential"</a> (Press release). June 20, 2013. Archived from <a href="javascript:if(confirm('https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm358082.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm358082.htm'" tppabs="https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm358082.htm" class="external text external">the original</a> on 14 January 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">2 February</span> 2016</span>.</cite></span></li><li id="cite_note-14"> <span id="mw-reference-text-cite_note-14" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://clincalc.com/DrugStats/Drugs/Levonorgestrel  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://clincalc.com/DrugStats/Drugs/Levonorgestrel'" tppabs="https://clincalc.com/DrugStats/Drugs/Levonorgestrel" class="external text external">"Levonorgestrel - Drug Usage Statistics"</a>. <i>ClinCalc</i><span class="reference-accessdate">. Retrieved <span class="nowrap">11 April</span> 2020</span>.</cite></span></li><li id="cite_note-Drugs.com-15"> <span id="mw-reference-text-cite_note-Drugs.com-15" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/international/levonorgestrel.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/international/levonorgestrel.html'" tppabs="https://www.drugs.com/international/levonorgestrel.html" class="external text external">"Levonorgestrel"</a>. <a href="javascript:if(confirm('https://web.archive.org/web/20170803221748/https://www.drugs.com/international/levonorgestrel.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170803221748/https://www.drugs.com/international/levonorgestrel.html'" tppabs="https://web.archive.org/web/20170803221748/https://www.drugs.com/international/levonorgestrel.html" class="external text external">Archived</a> from the original on 2017-08-03<span class="reference-accessdate">. Retrieved <span class="nowrap">2017-08-03</span></span>.</cite></span></li><li id="cite_note-pmid26732558-16"> <span id="mw-reference-text-cite_note-pmid26732558-16" class="mw-reference-text"><cite id="CITEREFFriend2016" class="citation journal cs1">Friend DR (October 2016). "Development of controlled release systems over the past 50years in the area of contraception". <i>Journal of Controlled Release</i>. <b>240</b>: 235–241. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.jconrel.2015.12.043  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.jconrel.2015.12.043'" tppabs="https://doi.org/10.1016%2Fj.jconrel.2015.12.043" class="external text external">10.1016/j.jconrel.2015.12.043</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26732558  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26732558'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26732558" class="external text external">26732558</a>.</cite></span></li><li id="cite_note-Bao_Q_2018-17"> <span id="mw-reference-text-cite_note-Bao_Q_2018-17" class="mw-reference-text"><cite id="CITEREFBaoGuPriceZou2018" class="citation journal cs1">Bao Q, Gu B, Price CF, Zou Y, Wang Y, Kozak D, Choi S, Burgess DJ (October 2018). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6622171  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6622171'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6622171" class="external text external">"Manufacturing and characterization of long-acting levonorgestrel intrauterine systems"</a>. <i>International Journal of Pharmaceutics</i>. <b>550</b> (1–2): 447–454. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.ijpharm.2018.09.004  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.ijpharm.2018.09.004'" tppabs="https://doi.org/10.1016%2Fj.ijpharm.2018.09.004" class="external text external">10.1016/j.ijpharm.2018.09.004</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6622171  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6622171'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6622171" class="external text external">6622171</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/30195080  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/30195080'" tppabs="https://pubmed.ncbi.nlm.nih.gov/30195080" class="external text external">30195080</a>.</cite></span></li><li id="cite_note-Trussell_2011-18"> <span id="mw-reference-text-cite_note-Trussell_2011-18" class="mw-reference-text"><cite id="CITEREFTrussellSchwarz2011" class="citation book cs1">Trussell J, Schwarz EB (2011). "Emergency contraception".  In Hatcher RA, Trussell J, Nelson AL, Cates W Jr, Kowal D, Policar MS (eds.). <i>Contraceptive technology</i> (20th revised ed.). New York: Ardent Media. pp.<span>&nbsp;</span>113–145. ISBN<span>&nbsp;</span><bdi>978-1-59708-004-0</bdi>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0091-9721  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0091-9721'" tppabs="https://www.worldcat.org/issn/0091-9721" class="external text external">0091-9721</a>. OCLC<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/oclc/781956734  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/oclc/781956734'" tppabs="https://www.worldcat.org/oclc/781956734" class="external text external">781956734</a>.</cite> p. 121:<blockquote>Mechanism of action<br>Copper-releasing IUCs<br>When used as a regular or emergency method of contraception, copper-releasing IUCs act primarily to prevent fertilization. Emergency insertion of a copper IUC is significantly more effective than the use of ECPs, reducing the risk of pregnancy following unprotected intercourse by more than 99%.<sup>2,3</sup> This very high level of effectiveness implies that emergency insertion of a copper IUC must prevent some pregnancies after fertilization.<br>Emergency contraceptive pills<br>To make an informed choice, women must know that ECPs—like the birth control pill, patch, ring, shot, and implant,<sup>76</sup> and even like breastfeeding<sup>77</sup>—prevent pregnancy primarily by delaying or inhibiting ovulation and inhibiting fertilization, but may at times inhibit implantation of a fertilized egg in the endometrium. However, women should also be informed that the best available evidence indicates that ECPs prevent pregnancy by mechanisms that do not involve interference with post-fertilization events.<br>ECPs do not cause abortion<sup>78</sup> or harm an established pregnancy. Pregnancy begins with implantation according to medical authorities such as the US FDA, the National Institutes of Health<sup>79</sup> and the American College of Obstetricians and Gynecologists (ACOG).<sup>80</sup><br><i>Ulipristal acetate (UPA).</i> One study has demonstrated that UP can delay ovulation.<sup>81</sup>... Another study found that UPA altered the endometrium, but whether this change would inhibit implantation is unknown.<sup>82</sup><br>p. 122:<br><i>Progestin-only emergency contraceptive pills.</i> Early treatment with ECPs containing only the progestin levonorgestrel has been show to impair the ovulatory process and luteal function.<sup>83–87</sup><br>p. 123:<br><i>Combined emergency contraceptive pills.</i> Several clinical studies have shown that combined ECPs containing ethinyl estradiol and levonorgestrel can inhibit or delay ovulation.<sup>107–110</sup></blockquote></span></li><li id="cite_note-FSRH_EC_2012-19"> <span id="mw-reference-text-cite_note-FSRH_EC_2012-19" class="mw-reference-text"><cite id="CITEREFRCOG_Faculty_of_SexualReproductive_HealthcareClinical_Effectiveness_Unit2012" class="citation journal cs1">RCOG Faculty of Sexual; Reproductive Healthcare; Clinical Effectiveness Unit (January 2012). <a href="javascript:if(confirm('http://www.fsrh.org/pdfs/CEUguidanceEmergencyContraception11.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.fsrh.org/pdfs/CEUguidanceEmergencyContraception11.pdf'" tppabs="http://www.fsrh.org/pdfs/CEUguidanceEmergencyContraception11.pdf" class="external text external">"Clinical guidance: emergency contraception"</a> <span class="cs1-format">(PDF)</span>. <i>Clinical Guidance</i>. London: Royal College of Obstetricians and Gynaecologists. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1755-103X  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1755-103X'" tppabs="https://www.worldcat.org/issn/1755-103X" class="external text external">1755-103X</a>. <a href="javascript:if(confirm('https://web.archive.org/web/20120526135043/http://www.fsrh.org/pdfs/CEUguidanceEmergencyContraception11.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20120526135043/http://www.fsrh.org/pdfs/CEUguidanceEmergencyContraception11.pdf'" tppabs="https://web.archive.org/web/20120526135043/http://www.fsrh.org/pdfs/CEUguidanceEmergencyContraception11.pdf" class="external text external">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 2012-05-26<span class="reference-accessdate">. Retrieved <span class="nowrap">2012-04-30</span></span>.</cite> p.3:<blockquote>How does EC work?<br>In 2002, a judicial review ruled that pregnancy begins at implantation, not fertilisation.<sup>8</sup> The possible mechanisms of action should be explained to the patient as some methods may not be acceptable, depending on individual beliefs about the onset of pregnancy and abortion.<br>Copper-bearing intrauterine device (Cu-IUD). Copper is toxic to the ovum and sperm and thus the copper-bearing intrauterine device (Cu-IUD) is effective immediately after insertion and works primarily by inhibiting fertilisation.<sup>9–11</sup> A systematic review on mechanisms of action of IUDs showed that both pre- and postfertilisation effects contribute to efficacy.<sup>11</sup> If fertilisation has already occurred, it is accepted that there is an anti-implantation effect,<sup>12,13</sup><br>Levonorgestrel (LNG). The precise mode of action of levonorgestrel (LNG) is incompletely understood but it is thought to work primarily by inhibition of ovulation.<sup>16,17</sup><br>Ulipristal acetate (UPA). UPA’s primary mechanism of action is thought to be inhibition or delay of ovulation.<sup>2</sup></blockquote></span></li><li id="cite_note-WHO_2010-20"> <span id="mw-reference-text-cite_note-WHO_2010-20" class="mw-reference-text"><cite id="CITEREFUNDP/UNFPA/WHO/World_Bank_Special_Programme_of_Research,_Development_and_Research_Training_in_Human_Reproduction_(HRP)2010" class="citation web cs1">UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP) (March 25, 2010). <a href="javascript:if(confirm('http://whqlibdoc.who.int/hq/2010/WHO_RHR_HRP_10.06_eng.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://whqlibdoc.who.int/hq/2010/WHO_RHR_HRP_10.06_eng.pdf'" tppabs="http://whqlibdoc.who.int/hq/2010/WHO_RHR_HRP_10.06_eng.pdf" class="external text external">"Fact sheet on the safety of levonorgestrel-alone emergency contraceptive pills (LNG ECPs)"</a> <span class="cs1-format">(PDF)</span>. Geneva: World Health Organization. <a href="javascript:if(confirm('https://web.archive.org/web/20120316134151/http://whqlibdoc.who.int/hq/2010/WHO_RHR_HRP_10.06_eng.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20120316134151/http://whqlibdoc.who.int/hq/2010/WHO_RHR_HRP_10.06_eng.pdf'" tppabs="https://web.archive.org/web/20120316134151/http://whqlibdoc.who.int/hq/2010/WHO_RHR_HRP_10.06_eng.pdf" class="external text external">Archived</a> <span class="cs1-format">(PDF)</span> from the original on March 16, 2012.</cite><blockquote>Can LNG ECPs cause an abortion?<br>LNG ECPs do not interrupt an established pregnancy or harm a developing embryo.<sup>15</sup> The evidence available to date shows that LNG ECP use does not prevent a fertilized egg from attaching to the uterine lining. The primary mechanism of action is to stop or disrupt ovulation; LNG ECP use may also prevent the sperm and egg from meeting.<sup>16</sup></blockquote></span></li><li id="cite_note-Speroff_2011-21"> <span id="mw-reference-text-cite_note-Speroff_2011-21" class="mw-reference-text"><cite id="CITEREFSperoffDarney2011" class="citation book cs1">Speroff L, Darney PD (2011). "Special uses of oral contraception: emergency contraception, the progestin-only minipill". <i>A clinical guide for contraception</i> (5th ed.). Philadelphia: Lippincott Williams &amp; Wilkins. pp.<span>&nbsp;</span>153–166. ISBN<span>&nbsp;</span><bdi>978-1-60831-610-6</bdi>.</cite> p. 155: <blockquote>Emergency postcoital contraception<br>Levonorgestrel<br>Mechanism and efficacy</blockquote></span></li><li id="cite_note-Belluck_2012b-22"> <span id="mw-reference-text-cite_note-Belluck_2012b-22" class="mw-reference-text"><cite id="CITEREFBelluck2012" class="citation news cs1">Belluck P (June 6, 2012). <a href="javascript:if(confirm('https://www.nytimes.com/2012/06/06/health/research/morning-after-pills-dont-block-implantation-science-suggests.html?pagewanted=all  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nytimes.com/2012/06/06/health/research/morning-after-pills-dont-block-implantation-science-suggests.html?pagewanted=all'" tppabs="https://www.nytimes.com/2012/06/06/health/research/morning-after-pills-dont-block-implantation-science-suggests.html?pagewanted=all" class="external text external">"No abortion role seen for morning-after pill"</a>. <i>The New York Times</i>. p.<span>&nbsp;</span>A1. <a href="javascript:if(confirm('https://web.archive.org/web/20170227112421/http://www.nytimes.com/2012/06/06/health/research/morning-after-pills-dont-block-implantation-science-suggests.html?pagewanted=all  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170227112421/http://www.nytimes.com/2012/06/06/health/research/morning-after-pills-dont-block-implantation-science-suggests.html?pagewanted=all'" tppabs="https://web.archive.org/web/20170227112421/http://www.nytimes.com/2012/06/06/health/research/morning-after-pills-dont-block-implantation-science-suggests.html?pagewanted=all" class="external text external">Archived</a> from the original on February 27, 2017.</cite><br><cite class="citation news cs1">Belluck, Pam (June 6, 2012). <a href="javascript:if(confirm('https://www.nytimes.com/2012/06/06/health/research/medications-nickname-may-have-helped-in-its-politcization.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nytimes.com/2012/06/06/health/research/medications-nickname-may-have-helped-in-its-politcization.html'" tppabs="https://www.nytimes.com/2012/06/06/health/research/medications-nickname-may-have-helped-in-its-politcization.html" class="external text external">"Drug's nickname may have aided politicization"</a>. <i>The New York Times</i>. p.<span>&nbsp;</span>A14.</cite></span></li><li id="cite_note-FIGO_2011-23"> <span id="mw-reference-text-cite_note-FIGO_2011-23" class="mw-reference-text"><cite id="CITEREFInternational_Federation_of_Gynecology_and_Obstetrics_(FIGO)_and_International_Consortium_for_Emergency_Contraception_(ICEC)2011" class="citation web cs1">International Federation of Gynecology and Obstetrics (FIGO) and International Consortium for Emergency Contraception (ICEC) (April 4, 2011). <a href="javascript:if(confirm('http://www.figo.org/sites/default/files/uploads/MOA_FINAL_2011_ENG.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.figo.org/sites/default/files/uploads/MOA_FINAL_2011_ENG.pdf'" tppabs="http://www.figo.org/sites/default/files/uploads/MOA_FINAL_2011_ENG.pdf" class="external text external">"Mechanism of action: How do levonorgestrel-only emergency contraceptive pills (LNG ECPs) prevent pregnancy?"</a> <span class="cs1-format">(PDF)</span>. London: International Federation of Gynecology and Obstetrics. <a href="javascript:if(confirm('https://web.archive.org/web/20141229024754/http://www.figo.org/sites/default/files/uploads/MOA_FINAL_2011_ENG.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20141229024754/http://www.figo.org/sites/default/files/uploads/MOA_FINAL_2011_ENG.pdf'" tppabs="https://web.archive.org/web/20141229024754/http://www.figo.org/sites/default/files/uploads/MOA_FINAL_2011_ENG.pdf" class="external text external">Archived</a> <span class="cs1-format">(PDF)</span> from the original on December 29, 2014.</cite><blockquote>Levonorgestrel-only emergency contraceptive pills:<br>• Interfere with the process of ovulation;<br>• May possibly prevent the sperm and the egg from meeting.<br>Implications of the research:<br>• Inhibition or delay of ovulation is LNG ECPs principal and possibly only mechanism of action.<br>• Review of the evidence suggests that LNG-ECs cannot prevent implantation of a fertilized egg. Language on implantation should not be included in LNG ECP product labeling.<br>• The fact that LNG-ECs have no demonstrated effect on implantation explains why they are not 100% effective in preventing pregnancy, and are less effective the later they are taken. Women should be given a clear message that LNG-ECs are more effective the sooner they are taken.<br>• LNG ECPs do not interrupt a pregnancy (by any definition of the beginning of pregnancy). However, LNG ECPs can prevent abortions by reducing unwanted pregnancies.</blockquote></span></li><li id="cite_note-Belluck_2013-24"> <span id="mw-reference-text-cite_note-Belluck_2013-24" class="mw-reference-text"><cite id="CITEREFBelluck2013" class="citation news cs1">Belluck, Pam (November 26, 2013). <a href="javascript:if(confirm('https://www.nytimes.com/2013/11/27/us/shift-on-birth-control-pill-may-affect-court-cases.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nytimes.com/2013/11/27/us/shift-on-birth-control-pill-may-affect-court-cases.html'" tppabs="https://www.nytimes.com/2013/11/27/us/shift-on-birth-control-pill-may-affect-court-cases.html" class="external text external">"New birth control label counters lawsuit claim; European authorities found that a drug like Plan B One-Step cannot prevent fertilized eggs from implanting in the womb"</a>. <i>The New York Times</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20140304233807/http://www.nytimes.com/2013/11/27/us/shift-on-birth-control-pill-may-affect-court-cases.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20140304233807/http://www.nytimes.com/2013/11/27/us/shift-on-birth-control-pill-may-affect-court-cases.html'" tppabs="https://web.archive.org/web/20140304233807/http://www.nytimes.com/2013/11/27/us/shift-on-birth-control-pill-may-affect-court-cases.html" class="external text external">Archived</a> from the original on March 4, 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">March 5,</span> 2014</span>.</cite><br><cite id="CITEREFHRA_Pharma2013" class="citation web cs1">HRA Pharma (November 2013). <a href="javascript:if(confirm('http://www.imb.ie/images/uploaded/swedocuments/2126041.PA1166_002_001.a60606c0-00f0-4866-bc34-91bdfd679b1e.000001PACKAGE%20LEAFLET%201.5.131128.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.imb.ie/images/uploaded/swedocuments/2126041.PA1166_002_001.a60606c0-00f0-4866-bc34-91bdfd679b1e.000001PACKAGE%20LEAFLET%201.5.131128.pdf'" tppabs="http://www.imb.ie/images/uploaded/swedocuments/2126041.PA1166_002_001.a60606c0-00f0-4866-bc34-91bdfd679b1e.000001PACKAGE%20LEAFLET%201.5.131128.pdf" class="external text external">"NorLevo 1.5 mg tablet Patient Information Leaflet (PIL)"</a> <span class="cs1-format">(PDF)</span>. Dublin: Irish Medicines Board. <a href="javascript:if(confirm('https://web.archive.org/web/20140305170311/http://www.imb.ie/images/uploaded/swedocuments/2126041.PA1166_002_001.a60606c0-00f0-4866-bc34-91bdfd679b1e.000001PACKAGE%20LEAFLET%201.5.131128.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20140305170311/http://www.imb.ie/images/uploaded/swedocuments/2126041.PA1166_002_001.a60606c0-00f0-4866-bc34-91bdfd679b1e.000001PACKAGE%20LEAFLET%201.5.131128.pdf'" tppabs="https://web.archive.org/web/20140305170311/http://www.imb.ie/images/uploaded/swedocuments/2126041.PA1166_002_001.a60606c0-00f0-4866-bc34-91bdfd679b1e.000001PACKAGE%20LEAFLET%201.5.131128.pdf" class="external text external">Archived</a> <span class="cs1-format">(PDF)</span> from the original on March 5, 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">March 5,</span> 2014</span>. <q>NorLevo works by stopping your ovaries from releasing an egg. It cannot stop a fertilized egg from attaching to the womb.</q></cite><br><cite class="citation web cs1">HRA Pharma (November 2013). <a href="javascript:if(confirm('https://web.archive.org/web/20120615184048/http://www.medicines.ie/medicine/11933/SPC/Norlevo+1.5mg+tablet  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20120615184048/http://www.medicines.ie/medicine/11933/SPC/Norlevo+1.5mg+tablet#PHARMACODYNAMIC_PROPS'" tppabs="https://web.archive.org/web/20120615184048/http://www.medicines.ie/medicine/11933/SPC/Norlevo+1.5mg+tablet#PHARMACODYNAMIC_PROPS" class="external text external">"NorLevo 1.5 mg tablet Summary of Product Characteristics (SPC)"</a>. Dublin: Irish Pharmaceutical Healthcare Association. Archived from <a href="javascript:if(confirm('http://www.medicines.ie/medicine/11933/SPC/Norlevo+1.5mg+tablet/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.medicines.ie/medicine/11933/SPC/Norlevo+1.5mg+tablet/#PHARMACODYNAMIC_PROPS'" tppabs="http://www.medicines.ie/medicine/11933/SPC/Norlevo+1.5mg+tablet/#PHARMACODYNAMIC_PROPS" class="external text external">the original</a> on June 15, 2012<span class="reference-accessdate">. Retrieved <span class="nowrap">March 5,</span> 2014</span>.</cite><br><cite id="CITEREFEuropean_Medicines_Agency2014" class="citation news cs1">European Medicines Agency (January 24, 2014). <a href="javascript:if(confirm('http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/01/news_detail_002010.jsp&mid=WC0b01ac058004d5c1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/01/news_detail_002010.jsp&mid=WC0b01ac058004d5c1'" tppabs="http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/01/news_detail_002010.jsp&mid=WC0b01ac058004d5c1" class="external text external">"Review of emergency contraceptives started"</a>. London: European Medicines Agency. <a href="javascript:if(confirm('https://web.archive.org/web/20140327002519/http://www.ema.europa.eu/ema/index.jsp?curl=pages%2Fnews_and_events%2Fnews%2F2014%2F01%2Fnews_detail_002010.jsp&mid=WC0b01ac058004d5c1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20140327002519/http://www.ema.europa.eu/ema/index.jsp?curl=pages%2Fnews_and_events%2Fnews%2F2014%2F01%2Fnews_detail_002010.jsp&mid=WC0b01ac058004d5c1'" tppabs="https://web.archive.org/web/20140327002519/http://www.ema.europa.eu/ema/index.jsp?curl=pages%2Fnews_and_events%2Fnews%2F2014%2F01%2Fnews_detail_002010.jsp&mid=WC0b01ac058004d5c1" class="external text external">Archived</a> from the original on March 27, 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">March 5,</span> 2014</span>.</cite></span></li><li id="cite_note-25"> <span id="mw-reference-text-cite_note-25" class="mw-reference-text"><cite id="CITEREFMozzanegaCosmi2011" class="citation journal cs1">Mozzanega B, Cosmi E (June 2011). "How do levonorgestrel-only emergency contraceptive pills prevent pregnancy? Some considerations". <i>Gynecological Endocrinology</i>. <b>27</b> (6): 439–42. doi:<a href="javascript:if(confirm('https://doi.org/10.3109%2F09513590.2010.501885  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3109%2F09513590.2010.501885'" tppabs="https://doi.org/10.3109%2F09513590.2010.501885" class="external text external">10.3109/09513590.2010.501885</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20670097  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20670097'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20670097" class="external text external">20670097</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:6431709  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:6431709'" tppabs="https://api.semanticscholar.org/CorpusID:6431709" class="external text external">6431709</a>.</cite></span></li><li id="cite_note-26"> <span id="mw-reference-text-cite_note-26" class="mw-reference-text"><cite id="CITEREFLeungLevineSoon2010" class="citation journal cs1">Leung VW, Levine M, Soon JA (February 2010). "Mechanisms of action of hormonal emergency contraceptives". <i>Pharmacotherapy</i>. <b>30</b> (2): 158–68. doi:<a href="javascript:if(confirm('https://doi.org/10.1592%2Fphco.30.2.158  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1592%2Fphco.30.2.158'" tppabs="https://doi.org/10.1592%2Fphco.30.2.158" class="external text external">10.1592/phco.30.2.158</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20099990  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20099990'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20099990" class="external text external">20099990</a>.</cite></span></li><li id="cite_note-Glasier_2011-27"> <span id="mw-reference-text-cite_note-Glasier_2011-27" class="mw-reference-text"><cite id="CITEREFGlasierCameronBlitheScherrer2011" class="citation journal cs1">Glasier A, Cameron ST, Blithe D, Scherrer B, Mathe H, Levy D, Gainer E, Ulmann A (October 2011). "Can we identify women at risk of pregnancy despite using emergency contraception? Data from randomized trials of ulipristal acetate and levonorgestrel". <i>Contraception</i>. <b>84</b> (4): 363–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.contraception.2011.02.009  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.contraception.2011.02.009'" tppabs="https://doi.org/10.1016%2Fj.contraception.2011.02.009" class="external text external">10.1016/j.contraception.2011.02.009</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21920190  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21920190'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21920190" class="external text external">21920190</a>.</cite></span></li><li id="cite_note-Trussell_2014-28"> <span id="mw-reference-text-cite_note-Trussell_2014-28" class="mw-reference-text"><cite id="CITEREFTrussellRaymondCleland2014" class="citation web cs1">Trussell J, Raymond EG, Cleland K (February 2014). <a href="javascript:if(confirm('http://ec.princeton.edu/questions/ec-review.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://ec.princeton.edu/questions/ec-review.pdf'" tppabs="http://ec.princeton.edu/questions/ec-review.pdf" class="external text external">"Emergency contraception: a last chance to prevent unintended pregnancy"</a> <span class="cs1-format">(PDF)</span>. Princeton: Office of Population Research at Princeton University, Association of Reproductive Health Professionals. <a href="javascript:if(confirm('https://web.archive.org/web/20100923040101/http://ec.princeton.edu/questions/ec-review.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20100923040101/http://ec.princeton.edu/questions/ec-review.pdf'" tppabs="https://web.archive.org/web/20100923040101/http://ec.princeton.edu/questions/ec-review.pdf" class="external text external">Archived</a> <span class="cs1-format">(PDF)</span> from the original on September 23, 2010<span class="reference-accessdate">. Retrieved <span class="nowrap">April 9,</span> 2014</span>.</cite></span></li><li id="cite_note-29"> <span id="mw-reference-text-cite_note-29" class="mw-reference-text"><cite id="CITEREFFestinPeregoudovSeucKiarie2017" class="citation journal cs1">Festin, Mario Philip R.; Peregoudov, Alexandre; Seuc, Armando; Kiarie, James; Temmerman, Marleen (2017-01-01). <a href="javascript:if(confirm('http://www.sciencedirect.com/science/article/pii/S0010782416303572  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.sciencedirect.com/science/article/pii/S0010782416303572'" tppabs="http://www.sciencedirect.com/science/article/pii/S0010782416303572" class="external text external">"Effect of BMI and body weight on pregnancy rates with LNG as emergency contraception: analysis of four WHO HRP studies"</a>. <i>Contraception</i>. <b>95</b> (1): 50–54. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.contraception.2016.08.001  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.contraception.2016.08.001'" tppabs="https://doi.org/10.1016%2Fj.contraception.2016.08.001" class="external text external">10.1016/j.contraception.2016.08.001</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0010-7824  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0010-7824'" tppabs="https://www.worldcat.org/issn/0010-7824" class="external text external">0010-7824</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357708  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357708'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357708" class="external text external">5357708</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27527670  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27527670'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27527670" class="external text external">27527670</a>.</cite></span></li><li id="cite_note-Kubíková2014-30"> <span id="mw-reference-text-cite_note-Kubíková2014-30" class="mw-reference-text"><cite id="CITEREFKubíková_D2014" class="citation journal cs1">Kubíková D (2014). <a href="javascript:if(confirm('https://www.praktickelekarenstvi.cz/pdfs/lek/2014/02/05.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.praktickelekarenstvi.cz/pdfs/lek/2014/02/05.pdf'" tppabs="https://www.praktickelekarenstvi.cz/pdfs/lek/2014/02/05.pdf" class="external text external">"<span>[</span>Menopausal symptoms and hormone replacement therapy<span>]</span>"</a> <span class="cs1-format">(PDF)</span>. <i>Praktické Lékárenství</i>. <b>10</b> (2): 68–73.</cite></span></li><li id="cite_note-Emergency_Contraception_-_ACOG-31"> <span id="mw-reference-text-cite_note-Emergency_Contraception_-_ACOG-31" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.acog.org/Clinical-Guidance-and-Publications/Practice-Bulletins/Committee-on-Practice-Bulletins-Gynecology/Emergency-Contraception?IsMobileSet=false  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.acog.org/Clinical-Guidance-and-Publications/Practice-Bulletins/Committee-on-Practice-Bulletins-Gynecology/Emergency-Contraception?IsMobileSet=false'" tppabs="https://www.acog.org/Clinical-Guidance-and-Publications/Practice-Bulletins/Committee-on-Practice-Bulletins-Gynecology/Emergency-Contraception?IsMobileSet=false" class="external text external">"Emergency Contraception - ACOG"</a>. <i>www.acog.org</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2019-06-01</span></span>.</cite></span></li><li id="cite_note-:0-32"> <span id="mw-reference-text-cite_note-:0-32" class="mw-reference-text"><cite id="CITEREFHansenSaseenTeal2007" class="citation journal cs1">Hansen LB, Saseen JJ, Teal SB (February 2007). "Levonorgestrel-only dosing strategies for emergency contraception". <i>Pharmacotherapy</i>. <b>27</b> (2): 278–84. doi:<a href="javascript:if(confirm('https://doi.org/10.1592%2Fphco.27.2.278  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1592%2Fphco.27.2.278'" tppabs="https://doi.org/10.1592%2Fphco.27.2.278" class="external text external">10.1592/phco.27.2.278</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17253917  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17253917'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17253917" class="external text external">17253917</a>.</cite></span></li><li id="cite_note-:1-33"> <span id="mw-reference-text-cite_note-:1-33" class="mw-reference-text"><cite id="CITEREFShohelRahmanZamanUddin2014" class="citation journal cs1">Shohel M, Rahman MM, Zaman A, Uddin MM, Al-Amin MM, Reza HM (April 2014). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977662  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977662'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977662" class="external text external">"A systematic review of effectiveness and safety of different regimens of levonorgestrel oral tablets for emergency contraception"</a>. <i>BMC Women's Health</i>. <b>14</b>: 54. doi:<a href="javascript:if(confirm('https://doi.org/10.1186%2F1472-6874-14-54  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1186%2F1472-6874-14-54'" tppabs="https://doi.org/10.1186%2F1472-6874-14-54" class="external text external">10.1186/1472-6874-14-54</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977662  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977662'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977662" class="external text external">3977662</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24708837  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24708837'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24708837" class="external text external">24708837</a>.</cite></span></li><li id="cite_note-:2-34"> <span id="mw-reference-text-cite_note-:2-34" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.mayoclinic.org/drugs-supplements/estradiol-and-levonorgestrel-transdermal-route/description/drg-20112971  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.mayoclinic.org/drugs-supplements/estradiol-and-levonorgestrel-transdermal-route/description/drg-20112971'" tppabs="https://www.mayoclinic.org/drugs-supplements/estradiol-and-levonorgestrel-transdermal-route/description/drg-20112971" class="external text external">"Estradiol And Levonorgestrel (Transdermal Route) Description and Brand Names - Mayo Clinic"</a>. <i>www.mayoclinic.org</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2019-06-01</span></span>.</cite></span></li><li id="cite_note-:3-35"> <span id="mw-reference-text-cite_note-:3-35" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021885lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021885lbl.pdf'" tppabs="https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021885lbl.pdf" class="external text external">"Climara Pro® (Estradiol/Levonorgestrel Transdermal System)"</a> <span class="cs1-format">(PDF)</span>. <i>Food and Drug Administration</i>.</cite></span></li><li id="cite_note-36"> <span id="mw-reference-text-cite_note-36" class="mw-reference-text"><cite id="CITEREFMueckRömer2018" class="citation journal cs1">Mueck AO, Römer T (July 2018). "Choice of progestogen for endometrial protection in combination with transdermal estradiol in menopausal women". <i>Hormone Molecular Biology and Clinical Investigation</i>. <b>37</b> (2). doi:<a href="javascript:if(confirm('https://doi.org/10.1515%2Fhmbci-2018-0033  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1515%2Fhmbci-2018-0033'" tppabs="https://doi.org/10.1515%2Fhmbci-2018-0033" class="external text external">10.1515/hmbci-2018-0033</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/30063464  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/30063464'" tppabs="https://pubmed.ncbi.nlm.nih.gov/30063464" class="external text external">30063464</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:51886877  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:51886877'" tppabs="https://api.semanticscholar.org/CorpusID:51886877" class="external text external">51886877</a>.</cite></span></li><li id="cite_note-Jeff2005-37"> <span id="mw-reference-text-cite_note-Jeff2005-37" class="mw-reference-text"><cite id="CITEREFJensen2005" class="citation journal cs1">Jensen JT (September 2005). "Contraceptive and therapeutic effects of the levonorgestrel intrauterine system: an overview". <i>Obstetrical &amp; Gynecological Survey</i>. <b>60</b> (9): 604–12. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2F01.ogx.0000175805.90122.af  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2F01.ogx.0000175805.90122.af'" tppabs="https://doi.org/10.1097%2F01.ogx.0000175805.90122.af" class="external text external">10.1097/01.ogx.0000175805.90122.af</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16121115  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16121115'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16121115" class="external text external">16121115</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:43177026  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:43177026'" tppabs="https://api.semanticscholar.org/CorpusID:43177026" class="external text external">43177026</a>.</cite></span></li><li id="cite_note-pmid18803473-38"> <span id="mw-reference-text-cite_note-pmid18803473-38" class="mw-reference-text"><cite id="CITEREFBenagianoGabelnickFarris2014" class="citation journal cs1">Benagiano, Giuseppe; Gabelnick, Henry; Farris, Manuela (2014). "Contraceptive devices: subcutaneous delivery systems". <i>Expert Review of Medical Devices</i>. <b>5</b> (5): 623–637. doi:<a href="javascript:if(confirm('https://doi.org/10.1586%2F17434440.5.5.623  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1586%2F17434440.5.5.623'" tppabs="https://doi.org/10.1586%2F17434440.5.5.623" class="external text external">10.1586/17434440.5.5.623</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1743-4440  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1743-4440'" tppabs="https://www.worldcat.org/issn/1743-4440" class="external text external">1743-4440</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18803473  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18803473'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18803473" class="external text external">18803473</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:207201811  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:207201811'" tppabs="https://api.semanticscholar.org/CorpusID:207201811" class="external text external">207201811</a>.</cite></span></li><li id="cite_note-PlanB_One-Step-Label-39"> <span id="mw-reference-text-cite_note-PlanB_One-Step-Label-39" class="mw-reference-text"><a href="javascript:if(confirm('https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021998lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021998lbl.pdf'" tppabs="https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021998lbl.pdf" class="external free external">https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021998lbl.pdf</a></span></li><li id="cite_note-40"> <span id="mw-reference-text-cite_note-40" class="mw-reference-text"><cite class="citation web cs1">HRA Pharma (November 2013). <a href="javascript:if(confirm('https://web.archive.org/web/20120615184048/http://www.medicines.ie/medicine/11933/SPC/Norlevo+1.5mg+tablet  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20120615184048/http://www.medicines.ie/medicine/11933/SPC/Norlevo+1.5mg+tablet#UNDESIRABLE_EFFECTS'" tppabs="https://web.archive.org/web/20120615184048/http://www.medicines.ie/medicine/11933/SPC/Norlevo+1.5mg+tablet#UNDESIRABLE_EFFECTS" class="external text external">"NorLevo 1.5 mg tablet Summary of Product Characteristics (SPC)"</a>. Dublin: Irish Pharmaceutical Healthcare Association. Archived from <a href="javascript:if(confirm('http://www.medicines.ie/medicine/11933/SPC/Norlevo+1.5mg+tablet/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.medicines.ie/medicine/11933/SPC/Norlevo+1.5mg+tablet/#UNDESIRABLE_EFFECTS'" tppabs="http://www.medicines.ie/medicine/11933/SPC/Norlevo+1.5mg+tablet/#UNDESIRABLE_EFFECTS" class="external text external">the original</a> on June 15, 2012<span class="reference-accessdate">. Retrieved <span class="nowrap">April 9,</span> 2014</span>.</cite></span></li><li id="cite_note-pmid24708811-41"> <span id="mw-reference-text-cite_note-pmid24708811-41" class="mw-reference-text"><cite id="CITEREFChenWuZhu2014" class="citation journal cs1">Chen X, Wu X, Zhu H (April 2014). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3992142  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3992142'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3992142" class="external text external">"Acute urticaria as a side effect of the Mirena® (levonorgestrel-releasing intrauterine system): a case report"</a>. <i>BMC Research Notes</i>. <b>7</b>: 209. doi:<a href="javascript:if(confirm('https://doi.org/10.1186%2F1756-0500-7-209  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1186%2F1756-0500-7-209'" tppabs="https://doi.org/10.1186%2F1756-0500-7-209" class="external text external">10.1186/1756-0500-7-209</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3992142  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3992142'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3992142" class="external text external">3992142</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24708811  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24708811'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24708811" class="external text external">24708811</a>.</cite></span></li><li id="cite_note-pmid31990981-42"> <span id="mw-reference-text-cite_note-pmid31990981-42" class="mw-reference-text"><cite id="CITEREFConzMotaBahamondesTeixeira_Dória2020" class="citation journal cs1">Conz L, Mota BS, Bahamondes L, Teixeira Dória M, Françoise Mauricette Derchain S, Rieira R, Sarian LO (January 2020). "Levonorgestrel-releasing intrauterine system and breast cancer risk: A systematic review and meta-analysis". <i>Acta Obstet Gynecol Scand</i>. <b>99</b> (8): 970–982. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Faogs.13817  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Faogs.13817'" tppabs="https://doi.org/10.1111%2Faogs.13817" class="external text external">10.1111/aogs.13817</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/31990981  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/31990981'" tppabs="https://pubmed.ncbi.nlm.nih.gov/31990981" class="external text external">31990981</a>.</cite></span></li><li id="cite_note-43"> <span id="mw-reference-text-cite_note-43" class="mw-reference-text"><cite id="CITEREFMedicines_and_Healthcare_products_Regulatory_Agency2016" class="citation web cs1">Medicines and Healthcare products Regulatory Agency (15 September 2016). <a href="javascript:if(confirm('https://web.archive.org/web/20170121212031/https://www.gov.uk/drug-safety-update/levonorgestrel-containing-emergency-hormonal-contraception-advice-on-interactions-with-hepatic-enzyme-inducers-and-contraceptive-efficacy  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170121212031/https://www.gov.uk/drug-safety-update/levonorgestrel-containing-emergency-hormonal-contraception-advice-on-interactions-with-hepatic-enzyme-inducers-and-contraceptive-efficacy'" tppabs="https://web.archive.org/web/20170121212031/https://www.gov.uk/drug-safety-update/levonorgestrel-containing-emergency-hormonal-contraception-advice-on-interactions-with-hepatic-enzyme-inducers-and-contraceptive-efficacy" class="external text external">"Levonorgestrel-containing emergency hormonal contraception: advice on interactions with hepatic enzyme inducers and contraceptive efficacy"</a>. <i>GOV.UK</i>. Archived from <a href="javascript:if(confirm('https://www.gov.uk/drug-safety-update/levonorgestrel-containing-emergency-hormonal-contraception-advice-on-interactions-with-hepatic-enzyme-inducers-and-contraceptive-efficacy  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.gov.uk/drug-safety-update/levonorgestrel-containing-emergency-hormonal-contraception-advice-on-interactions-with-hepatic-enzyme-inducers-and-contraceptive-efficacy'" tppabs="https://www.gov.uk/drug-safety-update/levonorgestrel-containing-emergency-hormonal-contraception-advice-on-interactions-with-hepatic-enzyme-inducers-and-contraceptive-efficacy" class="external text external">the original</a> on 21 January 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">6 June</span> 2017</span>.</cite></span></li><li id="cite_note-pmid20933120-44"> <span id="mw-reference-text-cite_note-pmid20933120-44" class="mw-reference-text"><cite id="CITEREFNieschlag2010" class="citation journal cs1">Nieschlag E (November 2010). <a href="javascript:if(confirm('http://www.kup.at/kup/pdf/10172.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.kup.at/kup/pdf/10172.pdf'" tppabs="http://www.kup.at/kup/pdf/10172.pdf" class="external text external">"Clinical trials in male hormonal contraception"</a> <span class="cs1-format">(PDF)</span>. <i>Contraception</i>. <b>82</b> (5): 457–70. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.contraception.2010.03.020  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.contraception.2010.03.020'" tppabs="https://doi.org/10.1016%2Fj.contraception.2010.03.020" class="external text external">10.1016/j.contraception.2010.03.020</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20933120  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20933120'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20933120" class="external text external">20933120</a>.</cite></span></li><li id="cite_note-pmid7825629-45"> <span id="mw-reference-text-cite_note-pmid7825629-45" class="mw-reference-text"><cite id="CITEREFDarney1995" class="citation journal cs1">Darney PD (January 1995). "The androgenicity of progestins". <i>The American Journal of Medicine</i>. <b>98</b> (1A): 104S–110S. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fs0002-9343%2899%2980067-9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fs0002-9343%2899%2980067-9'" tppabs="https://doi.org/10.1016%2Fs0002-9343%2899%2980067-9" class="external text external">10.1016/s0002-9343(99)80067-9</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7825629  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7825629'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7825629" class="external text external">7825629</a>.</cite></span></li><li id="cite_note-KnausIsaacs2012-46"> <span id="mw-reference-text-cite_note-KnausIsaacs2012-46" class="mw-reference-text"><cite id="CITEREFKnausIsaacs2012" class="citation book cs1">Knaus JV, Isaacs JH (6 December 2012). <a href="javascript:if(confirm('https://books.google.com/books?id=dgnpBwAAQBAJ&pg=PA151  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=dgnpBwAAQBAJ&pg=PA151'" tppabs="https://books.google.com/books?id=dgnpBwAAQBAJ&pg=PA151" class="external text external"><i>Office Gynecology: Advanced Management Concepts</i></a>. Springer Science &amp; Business Media. pp.<span>&nbsp;</span>151–. ISBN<span>&nbsp;</span><bdi>978-1-4612-4340-3</bdi>. <a href="javascript:if(confirm('https://web.archive.org/web/20170908140504/https://books.google.com/books?id=dgnpBwAAQBAJ&pg=PA151  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170908140504/https://books.google.com/books?id=dgnpBwAAQBAJ&pg=PA151'" tppabs="https://web.archive.org/web/20170908140504/https://books.google.com/books?id=dgnpBwAAQBAJ&pg=PA151" class="external text external">Archived</a> from the original on 8 September 2017.</cite></span></li><li id="cite_note-GolanTashjian2011-47"> <span id="mw-reference-text-cite_note-GolanTashjian2011-47" class="mw-reference-text"><cite id="CITEREFGolanTashjianArmstrong2011" class="citation book cs1">Golan DE, Tashjian AH, Armstrong EJ (15 December 2011). <a href="javascript:if(confirm('https://books.google.com/books?id=WM7rvNUcrdsC&pg=PA516  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=WM7rvNUcrdsC&pg=PA516'" tppabs="https://books.google.com/books?id=WM7rvNUcrdsC&pg=PA516" class="external text external"><i>Principles of Pharmacology: The Pathophysiologic Basis of Drug Therapy</i></a>. Lippincott Williams &amp; Wilkins. pp.<span>&nbsp;</span>516–. ISBN<span>&nbsp;</span><bdi>978-1-60831-270-2</bdi>. <a href="javascript:if(confirm('https://web.archive.org/web/20170908140504/https://books.google.com/books?id=WM7rvNUcrdsC&pg=PA516  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170908140504/https://books.google.com/books?id=WM7rvNUcrdsC&pg=PA516'" tppabs="https://web.archive.org/web/20170908140504/https://books.google.com/books?id=WM7rvNUcrdsC&pg=PA516" class="external text external">Archived</a> from the original on 8 September 2017.</cite></span></li><li id="cite_note-BreastCancer1991-48"> <span id="mw-reference-text-cite_note-BreastCancer1991-48" class="mw-reference-text"><cite id="CITEREFCommittee_on_the_Relationship_Between_Oral_Contraceptives_and_BreastCancer1991" class="citation book cs1">Committee on the Relationship Between Oral Contraceptives and BreastCancer (1 January 1991). <a href="javascript:if(confirm('https://books.google.com/books?id=upYrAAAAYAAJ&pg=PA147  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=upYrAAAAYAAJ&pg=PA147'" tppabs="https://books.google.com/books?id=upYrAAAAYAAJ&pg=PA147" class="external text external"><i>Oral Contraceptives and Breast Cancer</i></a>. National Academies. pp.<span>&nbsp;</span>147–. NAP:13774. <a href="javascript:if(confirm('https://web.archive.org/web/20170908140504/https://books.google.com/books?id=upYrAAAAYAAJ&pg=PA147  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170908140504/https://books.google.com/books?id=upYrAAAAYAAJ&pg=PA147'" tppabs="https://web.archive.org/web/20170908140504/https://books.google.com/books?id=upYrAAAAYAAJ&pg=PA147" class="external text external">Archived</a> from the original on 8 September 2017.</cite></span></li><li id="cite_note-pmid23758160-49"> <span id="mw-reference-text-cite_note-pmid23758160-49" class="mw-reference-text"><cite id="CITEREFNeubauerMaZhouYu2013" class="citation journal cs1">Neubauer H, Ma Q, Zhou J, Yu Q, Ruan X, Seeger H, Fehm T, Mueck AO (October 2013). "Possible role of PGRMC1 in breast cancer development". <i>Climacteric</i>. <b>16</b> (5): 509–13. doi:<a href="javascript:if(confirm('https://doi.org/10.3109%2F13697137.2013.800038  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3109%2F13697137.2013.800038'" tppabs="https://doi.org/10.3109%2F13697137.2013.800038" class="external text external">10.3109/13697137.2013.800038</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23758160  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23758160'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23758160" class="external text external">23758160</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:29808177  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:29808177'" tppabs="https://api.semanticscholar.org/CorpusID:29808177" class="external text external">29808177</a>.</cite></span></li><li id="cite_note-pmid22335423-50"> <span id="mw-reference-text-cite_note-pmid22335423-50" class="mw-reference-text"><cite id="CITEREFRuanNeubauerYangSchneck2012" class="citation journal cs1">Ruan X, Neubauer H, Yang Y, Schneck H, Schultz S, Fehm T, Cahill MA, Seeger H, Mueck AO (October 2012). "Progestogens and membrane-initiated effects on the proliferation of human breast cancer cells". <i>Climacteric</i>. <b>15</b> (5): 467–72. doi:<a href="javascript:if(confirm('https://doi.org/10.3109%2F13697137.2011.648232  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3109%2F13697137.2011.648232'" tppabs="https://doi.org/10.3109%2F13697137.2011.648232" class="external text external">10.3109/13697137.2011.648232</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22335423  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22335423'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22335423" class="external text external">22335423</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:11302554  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:11302554'" tppabs="https://api.semanticscholar.org/CorpusID:11302554" class="external text external">11302554</a>.</cite></span></li><li id="cite_note-pmid31512725-51"> <span id="mw-reference-text-cite_note-pmid31512725-51" class="mw-reference-text"><cite id="CITEREFTrabertShermanKannanStanczyk2019" class="citation journal cs1">Trabert B, Sherman ME, Kannan N, Stanczyk FZ (September 2019). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156851  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156851'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156851" class="external text external">"Progesterone and breast cancer"</a>. <i>Endocr. Rev</i>. <b>41</b> (2): 320–344. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1210%2Fendrev%2Fbnz001  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1210%2Fendrev%2Fbnz001'" tppabs="https://doi.org/10.1210%2Fendrev%2Fbnz001" class="external text external">10.1210/endrev/bnz001</a></span>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156851  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156851'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156851" class="external text external">7156851</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/31512725  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/31512725'" tppabs="https://pubmed.ncbi.nlm.nih.gov/31512725" class="external text external">31512725</a>.</cite></span></li><li id="cite_note-pmid12826683-52"> <span id="mw-reference-text-cite_note-pmid12826683-52" class="mw-reference-text"><cite id="CITEREFMeriggiolaFarleyMbizvo2003" class="citation journal cs1">Meriggiola MC, Farley TM, Mbizvo MT (2003). "A review of androgen-progestin regimens for male contraception". <i>Journal of Andrology</i>. <b>24</b> (4): 466–83. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fj.1939-4640.2003.tb02695.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fj.1939-4640.2003.tb02695.x'" tppabs="https://doi.org/10.1002%2Fj.1939-4640.2003.tb02695.x" class="external text external">10.1002/j.1939-4640.2003.tb02695.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12826683  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12826683'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12826683" class="external text external">12826683</a>. <q>Based on animal studies and clinical studies in women, 19‐norderived progestins are known to be potent in terms of gonadotropin suppression (Couzinet et al, 1996). Among this class of steroidal compounds are norethisterone (NET), norethynodrel, and its dextrorotatory isomer LNG (ie, the biologically active form of this progestin). The progestins of this class are known to be potent suppressors of gonadotropin secretion, and when administered to men these compounds induced a profound suppression of sperm production (Frick, 1973). However, a decrease of libido and sexual potency was also reported, presumably due to the suppression of T production secondary to gonadotropin suppression (Kamischke et al, 2000b). Therefore, like other progestins available thus far, nor‐progestins should not be administered alone for male contraception because their residual androgenic activity is not sufficient to maintain androgen‐dependent physiological functions like libido or sexual potency (Kamischke et al, 2000a).</q></cite></span></li><li id="cite_note-Elks2014-53"> <span id="mw-reference-text-cite_note-Elks2014-53" class="mw-reference-text"><cite id="CITEREFElks2014" class="citation book cs1">Elks J (14 November 2014). <a href="javascript:if(confirm('https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA887  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA887'" tppabs="https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA887" class="external text external"><i>The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies</i></a>. Springer. pp.<span>&nbsp;</span>887–. ISBN<span>&nbsp;</span><bdi>978-1-4757-2085-3</bdi>. <a href="javascript:if(confirm('https://web.archive.org/web/20170908140504/https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA887  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170908140504/https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA887'" tppabs="https://web.archive.org/web/20170908140504/https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA887" class="external text external">Archived</a> from the original on 8 September 2017.</cite></span></li><li id="cite_note-IndexNominum2000-54"> <span id="mw-reference-text-cite_note-IndexNominum2000-54" class="mw-reference-text"><cite class="citation book cs1"><a href="javascript:if(confirm('https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA605  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA605'" tppabs="https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA605" class="external text external"><i>Index Nominum 2000: International Drug Directory</i></a>. Taylor &amp; Francis. 2000. pp.<span>&nbsp;</span>605–. ISBN<span>&nbsp;</span><bdi>978-3-88763-075-1</bdi>. <a href="javascript:if(confirm('https://web.archive.org/web/20170908140504/https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA605  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170908140504/https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA605'" tppabs="https://web.archive.org/web/20170908140504/https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA605" class="external text external">Archived</a> from the original on 2017-09-08.</cite></span></li><li id="cite_note-AlldredgeCorelli2012-55"> <span id="mw-reference-text-cite_note-AlldredgeCorelli2012-55" class="mw-reference-text"><cite id="CITEREFAlldredgeCorelliErnst2012" class="citation book cs1">Alldredge BK, Corelli RL, Ernst ME (1 February 2012). <a href="javascript:if(confirm('https://books.google.com/books?id=qcVpuHngXK0C&pg=PA1072  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=qcVpuHngXK0C&pg=PA1072'" tppabs="https://books.google.com/books?id=qcVpuHngXK0C&pg=PA1072" class="external text external"><i>Koda-Kimble and Young's Applied Therapeutics: The Clinical Use of Drugs</i></a>. Lippincott Williams &amp; Wilkins. pp.<span>&nbsp;</span>1072–. ISBN<span>&nbsp;</span><bdi>978-1-60913-713-7</bdi>. <a href="javascript:if(confirm('https://web.archive.org/web/20170908140504/https://books.google.com/books?id=qcVpuHngXK0C&pg=PA1072  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170908140504/https://books.google.com/books?id=qcVpuHngXK0C&pg=PA1072'" tppabs="https://web.archive.org/web/20170908140504/https://books.google.com/books?id=qcVpuHngXK0C&pg=PA1072" class="external text external">Archived</a> from the original on 8 September 2017.</cite></span></li><li id="cite_note-LaverySanfilippo2012-56"> <span id="mw-reference-text-cite_note-LaverySanfilippo2012-56" class="mw-reference-text"><cite id="CITEREFLaverySanfilippo2012" class="citation book cs1">Lavery JP, Sanfilippo JS (6 December 2012). <a href="javascript:if(confirm('https://books.google.com/books?id=l9XTBwAAQBAJ&pg=PA248  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=l9XTBwAAQBAJ&pg=PA248'" tppabs="https://books.google.com/books?id=l9XTBwAAQBAJ&pg=PA248" class="external text external"><i>Pediatric and Adolescent Obstetrics and Gynecology</i></a>. Springer Science &amp; Business Media. pp.<span>&nbsp;</span>248–. ISBN<span>&nbsp;</span><bdi>978-1-4612-5064-7</bdi>. <a href="javascript:if(confirm('https://web.archive.org/web/20170908140504/https://books.google.com/books?id=l9XTBwAAQBAJ&pg=PA248  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170908140504/https://books.google.com/books?id=l9XTBwAAQBAJ&pg=PA248'" tppabs="https://web.archive.org/web/20170908140504/https://books.google.com/books?id=l9XTBwAAQBAJ&pg=PA248" class="external text external">Archived</a> from the original on 8 September 2017.</cite></span></li><li id="cite_note-OffermannsRosenthal2008-57"> <span id="mw-reference-text-cite_note-OffermannsRosenthal2008-57" class="mw-reference-text"><cite id="CITEREFOffermannsRosenthal2008" class="citation book cs1">Offermanns S, Rosenthal W (14 August 2008). <a href="javascript:if(confirm('https://books.google.com/books?id=iwwo5gx8aX8C&pg=PA390  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=iwwo5gx8aX8C&pg=PA390'" tppabs="https://books.google.com/books?id=iwwo5gx8aX8C&pg=PA390" class="external text external"><i>Encyclopedia of Molecular Pharmacology</i></a>. Springer Science &amp; Business Media. pp.<span>&nbsp;</span>390–. ISBN<span>&nbsp;</span><bdi>978-3-540-38916-3</bdi>. <a href="javascript:if(confirm('https://web.archive.org/web/20170908140504/https://books.google.com/books?id=iwwo5gx8aX8C&pg=PA390  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170908140504/https://books.google.com/books?id=iwwo5gx8aX8C&pg=PA390'" tppabs="https://web.archive.org/web/20170908140504/https://books.google.com/books?id=iwwo5gx8aX8C&pg=PA390" class="external text external">Archived</a> from the original on 8 September 2017.</cite></span></li><li id="cite_note-GWU1987-58"> <span id="mw-reference-text-cite_note-GWU1987-58" class="mw-reference-text"><cite class="citation book cs1"><a href="javascript:if(confirm('https://books.google.com/books?id=zZhLAQAAIAAJ  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=zZhLAQAAIAAJ'" tppabs="https://books.google.com/books?id=zZhLAQAAIAAJ" class="external text external"><i>Population Reports: Injectables and implants</i></a>. Department of Medical and Public Affairs, George Washington University. 1987. <q>The Population Council also plans to test vaginal rings with two other progestins, ST-1435 and levonorgestrel acetate, alone and combined with ethinyl estradiol (168).</q></cite></span></li><li id="cite_note-pmid6658872-59"> <span id="mw-reference-text-cite_note-pmid6658872-59" class="mw-reference-text"><cite id="CITEREFCrabbéArcherBenagianoDiczfalusy1983" class="citation journal cs1">Crabbé P, Archer S, Benagiano G, Diczfalusy E, Djerassi C, Fried J, Higuchi T (March 1983). "Long-acting contraceptive agents: design of the WHO Chemical Synthesis Programme". <i>Steroids</i>. <b>41</b> (3): 243–53. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0039-128X%2883%2990095-8  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0039-128X%2883%2990095-8'" tppabs="https://doi.org/10.1016%2F0039-128X%2883%2990095-8" class="external text external">10.1016/0039-128X(83)90095-8</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/6658872  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/6658872'" tppabs="https://pubmed.ncbi.nlm.nih.gov/6658872" class="external text external">6658872</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:12896179  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:12896179'" tppabs="https://api.semanticscholar.org/CorpusID:12896179" class="external text external">12896179</a>.</cite></span></li><li id="cite_note-Meikle1999-60"> <span id="mw-reference-text-cite_note-Meikle1999-60" class="mw-reference-text"><cite id="CITEREFMeikle1999" class="citation book cs1">Meikle AW (1 June 1999). <a href="javascript:if(confirm('https://books.google.com/books?id=ja2nBgAAQBAJ&pg=PA383  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=ja2nBgAAQBAJ&pg=PA383'" tppabs="https://books.google.com/books?id=ja2nBgAAQBAJ&pg=PA383" class="external text external"><i>Hormone Replacement Therapy</i></a>. Springer Science &amp; Business Media. pp.<span>&nbsp;</span>383–. ISBN<span>&nbsp;</span><bdi>978-1-59259-700-0</bdi>. <q>The gonanes share the structural modifications found in the estranes and also possess [an ethyl] group at the position 13 and a keto group at position 3. Norgestrel was synthesized in 1963 and is a racemic mixture of dextro and levorotatory forms. The levorotatory form, levonorgestrel, provides the biological activity.</q></cite></span></li><li id="cite_note-SzejtliSzente2012-61"> <span id="mw-reference-text-cite_note-SzejtliSzente2012-61" class="mw-reference-text"><cite id="CITEREFSzejtliSzente2012" class="citation book cs1">Szejtli J, Szente L (6 December 2012). <a href="javascript:if(confirm('https://books.google.com/books?id=hkbqCAAAQBAJ&pg=PA317  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=hkbqCAAAQBAJ&pg=PA317'" tppabs="https://books.google.com/books?id=hkbqCAAAQBAJ&pg=PA317" class="external text external"><i>Proceedings of the Eighth International Symposium on Cyclodextrins: Budapest, Hungary, March 31–April 2, 1996</i></a>. Springer Science &amp; Business Media. pp.<span>&nbsp;</span>317–. ISBN<span>&nbsp;</span><bdi>978-94-011-5448-2</bdi>. <q>[Norgestrel] was discovered by Hughes et al. (1963).</q></cite></span></li><li id="cite_note-FilshieGuillebaud2013-62"> <span id="mw-reference-text-cite_note-FilshieGuillebaud2013-62" class="mw-reference-text"><cite id="CITEREFFilshieGuillebaud2013" class="citation book cs1">Filshie M, Guillebaud J (22 October 2013). <a href="javascript:if(confirm('https://books.google.com/books?id=Ug3-BAAAQBAJ&pg=PA12  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=Ug3-BAAAQBAJ&pg=PA12'" tppabs="https://books.google.com/books?id=Ug3-BAAAQBAJ&pg=PA12" class="external text external"><i>Contraception: Science and Practice</i></a>. Elsevier Science. pp.<span>&nbsp;</span>12–. ISBN<span>&nbsp;</span><bdi>978-1-4831-6366-6</bdi>. <q>Norgestrel, developed by Wyeth and patented in 1964, was the first progestogen to be manufactured by total chemical synthesis. It was subsequently licensed to Schering AG, who separated the racemic mixture into an inactive structural isomer l-norgestrel and the active d-norgestrel -- more usually known as dextronorgestrel and levonorgestrel respectively, because of the optical isomerism that each displays.</q></cite></span></li><li id="cite_note-Marks2010-63"> <span id="mw-reference-text-cite_note-Marks2010-63" class="mw-reference-text"><cite id="CITEREFMarks2010" class="citation book cs1">Marks L (2010). <a href="javascript:if(confirm('https://books.google.com/books?id=_i-s4biQs7MC&pg=PA76  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=_i-s4biQs7MC&pg=PA76'" tppabs="https://books.google.com/books?id=_i-s4biQs7MC&pg=PA76" class="external text external"><i>Sexual Chemistry: A History of the Contraceptive Pill</i></a>. Yale University Press. pp.<span>&nbsp;</span>73, 76. ISBN<span>&nbsp;</span><bdi>978-0-300-16791-7</bdi>. <q>In 1964 the pharmaceutical company Wyeth developed norgestrel, the first progestogen to be made from a total chemical synthesis. Subsequently licensed to Schering AG, norgestrel was used to develop levonorgestrel, another active progestogen later used for oral contraception.</q></cite></span></li><li id="cite_note-Pohl2004-64"> <span id="mw-reference-text-cite_note-Pohl2004-64" class="mw-reference-text"><cite id="CITEREFPohl2004" class="citation book cs1">Pohl WG (2004). <a href="javascript:if(confirm('https://books.google.com/books?id=PtTuOXYBi3IC&pg=PA150  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=PtTuOXYBi3IC&pg=PA150'" tppabs="https://books.google.com/books?id=PtTuOXYBi3IC&pg=PA150" class="external text external"><i>Die wissenschaftliche Welt von gestern: die Preisträger des Ignaz L. Lieben-Preises 1865-1937 und des Richard Lieben-Preises 1912-1928<span>&nbsp;</span>: ein Kapitel österreichischer Wissenschaftsgeschichte in Kurzbiografien</i></a>. Böhlau Verlag Wien. pp.<span>&nbsp;</span>150–. ISBN<span>&nbsp;</span><bdi>978-3-205-77303-0</bdi>. <q>[The contraceptive EUGYNON is launched in 1966. NEOGYNON follows in 1970.]</q></cite></span></li><li id="cite_note-Ortiz-GómezSantesmases2016-65"> <span id="mw-reference-text-cite_note-Ortiz-GómezSantesmases2016-65" class="mw-reference-text"><cite id="CITEREFOrtiz-GómezSantesmases2016" class="citation book cs1">Ortiz-Gómez T, Santesmases MJ (22 April 2016). <a href="javascript:if(confirm('https://books.google.com/books?id=snUGDAAAQBAJ&pg=PT175  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=snUGDAAAQBAJ&pg=PT175'" tppabs="https://books.google.com/books?id=snUGDAAAQBAJ&pg=PT175" class="external text external"><i>Gendered Drugs and Medicine: Historical and Socio-Cultural Perspectives</i></a>. Taylor &amp; Francis. pp.<span>&nbsp;</span>175–. ISBN<span>&nbsp;</span><bdi>978-1-317-12981-3</bdi>. <q>The 1966 marketing campaign for Schering's second contraceptive, Eugynon, [...] (Schering AG Berline 1966, 11). [...] In 1970 [Schering] had already conducted an opinion poll among doctors in the run up to the marketing campaign for the newly introduced Neogynon. [...]</q></cite></span></li><li id="cite_note-ToneWatkins2007-66"> <span id="mw-reference-text-cite_note-ToneWatkins2007-66" class="mw-reference-text"><cite id="CITEREFToneWatkins2007" class="citation book cs1">Tone A, Watkins ES (8 January 2007). <span class="cs1-lock-registration"><a href="javascript:if(confirm('https://archive.org/details/isbn_9780814783016  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://archive.org/details/isbn_9780814783016'" tppabs="https://archive.org/details/isbn_9780814783016" class="external text external"><i>Medicating Modern America: Prescription Drugs in History</i></a></span>. NYU Press. pp.<span>&nbsp;</span><a href="javascript:if(confirm('https://archive.org/details/isbn_9780814783016/page/118  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://archive.org/details/isbn_9780814783016/page/118'" tppabs="https://archive.org/details/isbn_9780814783016/page/118" class="external text external">118</a>–119. ISBN<span>&nbsp;</span><bdi>978-0-8147-8300-9</bdi>.</cite></span></li><li id="cite_note-Albach1993-67"> <span id="mw-reference-text-cite_note-Albach1993-67" class="mw-reference-text"><cite id="CITEREFAlbach1993" class="citation book cs1">Albach H (1993). <a href="javascript:if(confirm('https://books.google.com/books?id=jIi3AAAAIAAJ&q=neogynon  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=jIi3AAAAIAAJ&q=neogynon'" tppabs="https://books.google.com/books?id=jIi3AAAAIAAJ&q=neogynon" class="external text external"><i>Culture and Technical Innovation: A Cross-Cultural Analysis and Policy Recommendations</i></a>. Walter de Gruyter. p.<span>&nbsp;</span>952. ISBN<span>&nbsp;</span><bdi>978-3-11-013947-1</bdi>. <q>[Since the safety of ovulation inhibition by levonorgestrel was also proven in the clinical studies, the cycle was extremely stable and the side effects were low, the drug was on August 1, 1970 introduced as Neogynon 21 and Neogynon 28 in Germany on the market.] [...] After the OC market had risen sharply in 1968 and 1969, the launch of Neogynon / Schering and Stediril-d / Wyeth in August 1970 gave the market a fresh boost.]</q></cite></span></li><li id="cite_note-ApeloVeloso1970-68"> <span id="mw-reference-text-cite_note-ApeloVeloso1970-68" class="mw-reference-text"><cite id="CITEREFApeloVeloso1970" class="citation journal cs1">Apelo R, Veloso I (1970). "Results of a controlled study employing d-norgestrel and ethinyl estradiol". <i>Contraception</i>. <b>2</b> (6): 391–400. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0010-7824%2870%2980002-6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0010-7824%2870%2980002-6'" tppabs="https://doi.org/10.1016%2FS0010-7824%2870%2980002-6" class="external text external">10.1016/S0010-7824(70)80002-6</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0010-7824  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0010-7824'" tppabs="https://www.worldcat.org/issn/0010-7824" class="external text external">0010-7824</a>. <q>The results obtained in these series clinically confirmed the findings in animal work on the potency of d-norgestrel, i.e., that the biological activity of norgestrel resides largely in the d-enantlomer (5,6).</q></cite></span></li><li id="cite_note-BrosensVanAssche1971-69"> <span id="mw-reference-text-cite_note-BrosensVanAssche1971-69" class="mw-reference-text"><cite id="CITEREFBrosensVan_AsscheWijnants1971" class="citation journal cs1">Brosens I, Van Assche A, Wijnants P (1971). <a href="javascript:if(confirm('https://www.popline.org/node/485953  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.popline.org/node/485953'" tppabs="https://www.popline.org/node/485953" class="external text external">"Comparative clinical and morphological studies on 2 oral contraceptives which contain DL-norgestrel and D-norgestrel respectively"</a>. <i>Geburtshilfe und Frauenheilkunde</i>. <b>31</b> (3): 251–257. <q>Comparison of the effects of Eugynon and Neogynon (.05 mg ethinyl estradiol with .5 mg norgestrel or with .25 mg d-norgestrel, respectively) in 272 women is reported. The 2 preparations were comparable as regards effectiveness (100%), cycle control, and endometrial and cervical morphology. No clinical or biological complications occurred, and the incidence of minor side effects was very small. The d-norgestrel preparation (Neogynon) may be preferable for metabolic reasons because of its lower steroid dose.</q></cite></span></li><li id="cite_note-SchneiderSpona1974-70"> <span id="mw-reference-text-cite_note-SchneiderSpona1974-70" class="mw-reference-text"><cite id="CITEREFSchneiderSponaMatt1974" class="citation journal cs1">Schneider W, Spona J, Matt K (1974). "Inhibition of ovulation by means of a combined preparation with reduced amounts of active substance". <i>Contraception</i>. <b>9</b> (1): 81–92. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0010-7824%2874%2990096-1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0010-7824%2874%2990096-1'" tppabs="https://doi.org/10.1016%2F0010-7824%2874%2990096-1" class="external text external">10.1016/0010-7824(74)90096-1</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0010-7824  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0010-7824'" tppabs="https://www.worldcat.org/issn/0010-7824" class="external text external">0010-7824</a>.</cite></span></li><li id="cite_note-pmid4614952-71"> <span id="mw-reference-text-cite_note-pmid4614952-71" class="mw-reference-text"><cite id="CITEREFBrat1974" class="citation journal cs1">Brat T (1974). "Clinical trial with a new low oestrogen combined oral contraceptive". <i>Current Medical Research and Opinion</i>. <b>2</b> (8): 465–70. doi:<a href="javascript:if(confirm('https://doi.org/10.1185%2F03007997409115244  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1185%2F03007997409115244'" tppabs="https://doi.org/10.1185%2F03007997409115244" class="external text external">10.1185/03007997409115244</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/4614952  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/4614952'" tppabs="https://pubmed.ncbi.nlm.nih.gov/4614952" class="external text external">4614952</a>.</cite></span></li><li id="cite_note-Scharff1972-72"> <span id="mw-reference-text-cite_note-Scharff1972-72" class="mw-reference-text">Scharff, H. J. (1972). Clinical experience with Microlut. <i>Medical News Schering</i> No. 1 1972. p. 2-9. <a href="javascript:if(confirm('https://www.popline.org/node/488633  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.popline.org/node/488633'" tppabs="https://www.popline.org/node/488633" class="external free external">https://www.popline.org/node/488633</a></span></li><li id="cite_note-pmid4817042-73"> <span id="mw-reference-text-cite_note-pmid4817042-73" class="mw-reference-text"><cite id="CITEREFLambotteWerbrouck-Navette1974" class="citation journal cs1">Lambotte R, Werbrouck-Navette J (March 1974). <a href="javascript:if(confirm('https://www.popline.org/node/493200  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.popline.org/node/493200'" tppabs="https://www.popline.org/node/493200" class="external text external">"<span>[</span>Minipill as the new contraceptive method<span>]</span>"</a>. <i>Revue Medicale de Liege</i> (in French). <b>29</b> (6): 157–9. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/4817042  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/4817042'" tppabs="https://pubmed.ncbi.nlm.nih.gov/4817042" class="external text external">4817042</a>.</cite></span></li><li id="cite_note-KesserüLarrañaga1973-74"> <span id="mw-reference-text-cite_note-KesserüLarrañaga1973-74" class="mw-reference-text"><cite id="CITEREFKesserüLarrañagaParada1973" class="citation journal cs1">Kesserü E, Larrañaga A, Parada J (1973). "Postcoital contraception with D-norgestrel". <i>Contraception</i>. <b>7</b> (5): 367–379. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0010-7824%2873%2990139-X  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0010-7824%2873%2990139-X'" tppabs="https://doi.org/10.1016%2F0010-7824%2873%2990139-X" class="external text external">10.1016/0010-7824(73)90139-X</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0010-7824  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0010-7824'" tppabs="https://www.worldcat.org/issn/0010-7824" class="external text external">0010-7824</a>.</cite></span></li><li id="cite_note-RubioBerman1970-75"> <span id="mw-reference-text-cite_note-RubioBerman1970-75" class="mw-reference-text"><cite id="CITEREFRubioBermanLarranagaGuiloff1970" class="citation journal cs1">Rubio B, Berman E, Larranaga A, Guiloff E (1970). "A new postcoital oral contraceptive". <i>Contraception</i>. <b>1</b> (5): 303–314. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0010-7824%2870%2990016-8  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0010-7824%2870%2990016-8'" tppabs="https://doi.org/10.1016%2F0010-7824%2870%2990016-8" class="external text external">10.1016/0010-7824(70)90016-8</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0010-7824  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0010-7824'" tppabs="https://www.worldcat.org/issn/0010-7824" class="external text external">0010-7824</a>.</cite></span></li><li id="cite_note-Balaji2009-76"> <span id="mw-reference-text-cite_note-Balaji2009-76" class="mw-reference-text"><cite id="CITEREFBalaji2009" class="citation book cs1">Balaji (19 November 2009). <a href="javascript:if(confirm('https://books.google.com/books?id=xbp2B4fFL7wC&pg=RA1-PA569  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=xbp2B4fFL7wC&pg=RA1-PA569'" tppabs="https://books.google.com/books?id=xbp2B4fFL7wC&pg=RA1-PA569" class="external text external"><i>Textbook of Oral and Maxillofacial Surgery</i></a>. Elsevier India. p.<span>&nbsp;</span>569. ISBN<span>&nbsp;</span><bdi>978-81-312-0300-2</bdi>. <q>There are two main methods involving oral emergency pills, commonly misleadingly described as the 'morning-after pill'. The first older method, developed in the mid-1970s, involves two high-dose combined pills containing oestrogen (50 ug ethinyloestradiol) and progesterone (0.25 mg levonorgestrel): the Yuzpe regime (Schering PC4 or Ovran). The second involves progesterone only (0.75 mg levonorgestrel), and therefore, has a lower incidence of side effects, in particular vomiting (6%).</q></cite></span></li><li id="cite_note-pmid4844513-77"> <span id="mw-reference-text-cite_note-pmid4844513-77" class="mw-reference-text"><cite id="CITEREFYuzpeThurlowRamzyLeyshon1974" class="citation journal cs1">Yuzpe AA, Thurlow HJ, Ramzy I, Leyshon JI (August 1974). "Post coital contraception--A pilot study". <i>The Journal of Reproductive Medicine</i>. <b>13</b> (2): 53–8. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/4844513  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/4844513'" tppabs="https://pubmed.ncbi.nlm.nih.gov/4844513" class="external text external">4844513</a>.</cite></span></li><li id="cite_note-Farkas1978-78"> <span id="mw-reference-text-cite_note-Farkas1978-78" class="mw-reference-text">Farkas, M. (1978). Post-coital contraception with Postinor, a preparation containing 0.75 mg d-norgestrel. Magyar Nöorvosok Lapja, 41, 474. <a href="javascript:if(confirm('https://scholar.google.com/scholar?cluster=8190066278284376785  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://scholar.google.com/scholar?cluster=8190066278284376785'" tppabs="https://scholar.google.com/scholar?cluster=8190066278284376785" class="external free external">https://scholar.google.com/scholar?cluster=8190066278284376785</a></span></li><li id="cite_note-ArtiniGenazzani2001-79"> <span id="mw-reference-text-cite_note-ArtiniGenazzani2001-79" class="mw-reference-text"><cite id="CITEREFArtiniGenazzaniPetraglia2001" class="citation book cs1">Artini PG, Genazzani AR, Petraglia F (11 December 2001). <a href="javascript:if(confirm('https://books.google.com/books?id=dknDdAonzlUC&pg=PA96  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=dknDdAonzlUC&pg=PA96'" tppabs="https://books.google.com/books?id=dknDdAonzlUC&pg=PA96" class="external text external"><i>Advances in Gynecological Endocrinology</i></a>. CRC Press. pp.<span>&nbsp;</span>96–. ISBN<span>&nbsp;</span><bdi>978-1-84214-071-0</bdi>.</cite></span></li><li id="cite_note-pmid8473453-80"> <span id="mw-reference-text-cite_note-pmid8473453-80" class="mw-reference-text"><cite id="CITEREFHoKwan1993" class="citation journal cs1">Ho PC, Kwan MS (March 1993). "A prospective randomized comparison of levonorgestrel with the Yuzpe regimen in post-coital contraception". <i>Human Reproduction</i>. <b>8</b> (3): 389–92. doi:<a href="javascript:if(confirm('https://doi.org/10.1093%2Foxfordjournals.humrep.a138057  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Foxfordjournals.humrep.a138057'" tppabs="https://doi.org/10.1093%2Foxfordjournals.humrep.a138057" class="external text external">10.1093/oxfordjournals.humrep.a138057</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8473453  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8473453'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8473453" class="external text external">8473453</a>.</cite></span></li><li id="cite_note-King2013-81"> <span id="mw-reference-text-cite_note-King2013-81" class="mw-reference-text"><cite id="CITEREFKing2013" class="citation book cs1">King (21 October 2013). <a href="javascript:if(confirm('https://books.google.com/books?id=dbaNAQAAQBAJ&pg=PA493  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=dbaNAQAAQBAJ&pg=PA493'" tppabs="https://books.google.com/books?id=dbaNAQAAQBAJ&pg=PA493" class="external text external"><i>Varney's Midwifery</i></a>. Jones &amp; Bartlett Publishers. pp.<span>&nbsp;</span>493–. ISBN<span>&nbsp;</span><bdi>978-1-284-02542-2</bdi>.</cite></span></li><li id="cite_note-Harrison-Woolrych2015-82"> <span id="mw-reference-text-cite_note-Harrison-Woolrych2015-82" class="mw-reference-text"><cite id="CITEREFHarrison-Woolrych2015" class="citation book cs1">Harrison-Woolrych M (28 January 2015). <a href="javascript:if(confirm('https://books.google.com/books?id=A0ZvBgAAQBAJ&pg=PA205  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=A0ZvBgAAQBAJ&pg=PA205'" tppabs="https://books.google.com/books?id=A0ZvBgAAQBAJ&pg=PA205" class="external text external"><i>Medicines For Women</i></a>. Springer. pp.<span>&nbsp;</span>205–. ISBN<span>&nbsp;</span><bdi>978-3-319-12406-3</bdi>.</cite></span></li><li id="cite_note-CBSNews2013-83"> <span id="mw-reference-text-cite_note-CBSNews2013-83" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.cbsnews.com/news/fda-approves-over-the-counter-sales-of-plan-b-one-step-for-all-ages/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.cbsnews.com/news/fda-approves-over-the-counter-sales-of-plan-b-one-step-for-all-ages/'" tppabs="http://www.cbsnews.com/news/fda-approves-over-the-counter-sales-of-plan-b-one-step-for-all-ages/" class="external text external">"FDA approves over-the-counter sales of Plan B One-Step for all ages"</a>. <a href="javascript:if(confirm('https://web.archive.org/web/20170803212130/http://www.cbsnews.com/news/fda-approves-over-the-counter-sales-of-plan-b-one-step-for-all-ages/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170803212130/http://www.cbsnews.com/news/fda-approves-over-the-counter-sales-of-plan-b-one-step-for-all-ages/'" tppabs="https://web.archive.org/web/20170803212130/http://www.cbsnews.com/news/fda-approves-over-the-counter-sales-of-plan-b-one-step-for-all-ages/" class="external text external">Archived</a> from the original on 2017-08-03<span class="reference-accessdate">. Retrieved <span class="nowrap">2017-08-03</span></span>.</cite></span></li><li id="cite_note-Princeton2017-84"> <span id="mw-reference-text-cite_note-Princeton2017-84" class="mw-reference-text"><cite id="CITEREFTrussellCleland2007" class="citation web cs1">Trussell J, Cleland K (2007-04-10). <a href="javascript:if(confirm('http://ec.princeton.edu/questions/dedicated.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://ec.princeton.edu/questions/dedicated.html'" tppabs="http://ec.princeton.edu/questions/dedicated.html" class="external text external">"Emergency Contraceptive Pills Worldwide"</a>. Princeton University. <a href="javascript:if(confirm('https://web.archive.org/web/20070522214523/http://ec.princeton.edu/questions/dedicated.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20070522214523/http://ec.princeton.edu/questions/dedicated.html'" tppabs="https://web.archive.org/web/20070522214523/http://ec.princeton.edu/questions/dedicated.html" class="external text external">Archived</a> from the original on 2007-05-22<span class="reference-accessdate">. Retrieved <span class="nowrap">2007-05-28</span></span>.</cite></span></li><li id="cite_note-OatsAbraham2011-85"> <span id="mw-reference-text-cite_note-OatsAbraham2011-85" class="mw-reference-text"><cite id="CITEREFOatsAbraham2011" class="citation book cs1">Oats JJ, Abraham S (17 November 2011). <a href="javascript:if(confirm('https://books.google.com/books?id=oZjGAAAAQBAJ&pg=PA247  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=oZjGAAAAQBAJ&pg=PA247'" tppabs="https://books.google.com/books?id=oZjGAAAAQBAJ&pg=PA247" class="external text external"><i>Llewellyn-Jones Fundamentals of Obstetrics and Gynaecology E-Book</i></a>. Elsevier Health Sciences. pp.<span>&nbsp;</span>247–. ISBN<span>&nbsp;</span><bdi>978-0-7234-3719-2</bdi>.</cite></span></li><li id="cite_note-CarlsonEisenstat2004-86"> <span id="mw-reference-text-cite_note-CarlsonEisenstat2004-86" class="mw-reference-text"><cite id="CITEREFCarlsonEisenstatZiporyn2004" class="citation book cs1">Carlson KJ, Eisenstat SA, Ziporyn TD (2004). <span class="cs1-lock-registration"><a href="javascript:if(confirm('https://archive.org/details/newharvardguidet00carl  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://archive.org/details/newharvardguidet00carl'" tppabs="https://archive.org/details/newharvardguidet00carl" class="external text external"><i>The New Harvard Guide to Women's Health</i></a></span>. Harvard University Press. pp.<span>&nbsp;</span><a href="javascript:if(confirm('https://archive.org/details/newharvardguidet00carl/page/285  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://archive.org/details/newharvardguidet00carl/page/285'" tppabs="https://archive.org/details/newharvardguidet00carl/page/285" class="external text external">285</a>–. ISBN<span>&nbsp;</span><bdi>978-0-674-01282-0</bdi>.</cite></span></li><li id="cite_note-87"> <span id="mw-reference-text-cite_note-87" class="mw-reference-text"><cite id="CITEREFRankin2015" class="citation web cs1">Rankin, Kenrya (2015-10-22). <a href="javascript:if(confirm('http://www.colorlines.com/articles/policy-gives-native-women-equal-access-emergency-contraception  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.colorlines.com/articles/policy-gives-native-women-equal-access-emergency-contraception'" tppabs="http://www.colorlines.com/articles/policy-gives-native-women-equal-access-emergency-contraception" class="external text external">"This Policy Gives Native Women Equal Access to Emergency Contraception"</a>. Colorlines. <a href="javascript:if(confirm('https://web.archive.org/web/20151026014315/http://www.colorlines.com/articles/policy-gives-native-women-equal-access-emergency-contraception  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20151026014315/http://www.colorlines.com/articles/policy-gives-native-women-equal-access-emergency-contraception'" tppabs="https://web.archive.org/web/20151026014315/http://www.colorlines.com/articles/policy-gives-native-women-equal-access-emergency-contraception" class="external text external">Archived</a> from the original on 2015-10-26<span class="reference-accessdate">. Retrieved <span class="nowrap">2015-10-24</span></span>.</cite></span></li></ol></div></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<table role="presentation" class="mbox-small  sistersitebox" style="background-color:#f9f9f9;border:1px solid #aaa;color:#000">
<tbody><tr>
<td class="mbox-image"><figure-inline class="noviewer"><span><img src="../I/m/Commons-logo.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Commons-logo.svg.png" data-file-width="1024" data-file-height="1376" data-file-type="drawing" height="40" width="30"></span></figure-inline></td>
<td class="mbox-text plainlist">Wikimedia Commons has media related to <i><b><a href="javascript:if(confirm('https://commons.wikimedia.org/wiki/Special:Search/Levonorgestrel  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://commons.wikimedia.org/wiki/Special:Search/Levonorgestrel'" tppabs="https://commons.wikimedia.org/wiki/Special:Search/Levonorgestrel" title="commons:Special:Search/Levonorgestrel" class="external">Levonorgestrel</a></b></i>.</td></tr>
</tbody></table>
<ul><li><a href="javascript:if(confirm('https://www.britannica.com/EBchecked/topic/338040  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.britannica.com/EBchecked/topic/338040'" tppabs="https://www.britannica.com/EBchecked/topic/338040" class="external text external">Levonorgestrel</a><span> at the </span><i>Encyclopædia Britannica</i></li>
<li><a href="javascript:if(confirm('http://www.levonelle.co.uk/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.levonelle.co.uk/'" tppabs="http://www.levonelle.co.uk/" class="external text external">Levonelle</a> manufacturer's product information from Schering</li>
<li><a href="javascript:if(confirm('https://web.archive.org/web/20060925001403/http://www.ukmi.nhs.uk/NewMaterial/html/docs/levonorg.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20060925001403/http://www.ukmi.nhs.uk/NewMaterial/html/docs/levonorg.pdf'" tppabs="https://web.archive.org/web/20060925001403/http://www.ukmi.nhs.uk/NewMaterial/html/docs/levonorg.pdf" class="external text external">Monograph for levonorgestrel</a> - Uk Medicines Information</li>
<li><cite class="citation web cs1"><a href="javascript:if(confirm('https://druginfo.nlm.nih.gov/drugportal/name/levonorgestrel  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://druginfo.nlm.nih.gov/drugportal/name/levonorgestrel'" tppabs="https://druginfo.nlm.nih.gov/drugportal/name/levonorgestrel" class="external text external">"Levonorgestrel"</a>. <i>Drug Information Portal</i>. U.S. National Library of Medicine.</cite></li></ul>

<div role="navigation" class="navbox" aria-labelledby="Progestogens_and_antiprogestogens" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Progestogens_and_antiprogestogens" style="font-size:114%;margin:0 4em">Progestogens and antiprogestogens</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Progestogens<br>(and progestins)</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;background:#DDDDFF;"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="PR_agonists" scope="row" class="navbox-group" style="width:8em;;text-align:center;"><abbr>PR</abbr> agonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Progesterone derivatives:</i> Progesterone</li>
<li>Quingestrone</li></ul>

<ul><li><i>Retroprogesterone derivatives:</i> <a href="Dydrogesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dydrogesterone" title="Dydrogesterone">Dydrogesterone</a></li>
<li>Trengestone</li></ul>

<ul><li><i>17α-Hydroxyprogesterone (and closely related) derivatives:</i> <i>17α-Hydroxylated:</i> Acetomepregenol (mepregenol diacetate)</li>
<li>Algestone acetophenide (dihydroxyprogesterone acetophenide)</li>
<li>Anagestone acetate</li>
<li>Chlormadinone acetate</li>
<li>Chlormethenmadinone acetate</li>
<li>Cyproterone acetate</li>
<li>Delmadinone acetate</li>
<li>Flugestone acetate (flurogestone acetate)</li>
<li>Flumedroxone acetate</li>
<li>Hydroxyprogesterone acetate</li>
<li>Hydroxyprogesterone caproate</li>
<li>Hydroxyprogesterone heptanoate</li>
<li><a href="Medroxyprogesterone_acetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate">Medroxyprogesterone acetate</a><sup>#</sup></li>
<li>Megestrol acetate</li>
<li>Melengestrol acetate</li>
<li>Methenmadinone acetate</li>
<li>Osaterone acetate</li>
<li>Pentagestrone acetate</li>
<li>Proligestone; <i>17α-Methylated:</i> Medrogestone; <i>Others:</i> Haloprogesterone</li></ul>

<ul><li><i>19-Norprogesterone derivatives:</i> <i>17α-Hydroxylated:</i> Gestonorone caproate (gestronol hexanoate)</li>
<li>Nomegestrol acetate</li>
<li>Norgestomet</li>
<li>Segesterone acetate (nestorone, elcometrine); <i>17α-Methylated:</i> Demegestone</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Promegestone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Promegestone'" tppabs="https://ptable.com/wiki/compounds/A/Promegestone" title="Promegestone">Promegestone</a></li>
<li>Trimegestone</li></ul>

<ul><li><i>Testosterone derivatives:</i> <i>Estranes:</i> <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Danazol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Danazol'" tppabs="https://ptable.com/wiki/compounds/A/Danazol" title="Danazol">Danazol</a></li>
<li>Dimethisterone</li>
<li><a href="Ethisterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethisterone" title="Ethisterone">Ethisterone</a></li></ul>

<ul><li><i>19-Nortestosterone derivatives:</i> <i>Estranes:</i> <a href="Allylestrenol.htm" tppabs="https://ptable.com/wiki/compounds/A/Allylestrenol" title="Allylestrenol">Allylestrenol</a></li>
<li>Altrenogest</li>
<li>Dienogest</li>
<li><a href="Etynodiol_diacetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Etynodiol_diacetate" title="Etynodiol diacetate">Etynodiol diacetate</a></li>
<li>Lynestrenol</li>
<li><a href="Norethisterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Norethisterone" title="Norethisterone">Norethisterone (norethindrone)</a><sup>#</sup></li>
<li>Norethisterone acetate</li>
<li>Norethisterone enanthate</li>
<li>Noretynodrel</li>
<li>Norgesterone</li>
<li>Norgestrienone</li>
<li>Normethandrone (methylestrenolone)</li>
<li>Norvinisterone</li>
<li>Oxendolone</li>
<li>Quingestanol acetate</li>
<li>Tibolone; <i>Gonanes:</i> <a href="Desogestrel.htm" tppabs="https://ptable.com/wiki/compounds/A/Desogestrel" title="Desogestrel">Desogestrel</a></li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Etonogestrel  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Etonogestrel'" tppabs="https://ptable.com/wiki/compounds/A/Etonogestrel" title="Etonogestrel">Etonogestrel</a></li>
<li><a href="Gestodene.htm" tppabs="https://ptable.com/wiki/compounds/A/Gestodene" title="Gestodene">Gestodene</a></li>
<li><a href="Gestrinone.htm" tppabs="https://ptable.com/wiki/compounds/A/Gestrinone" title="Gestrinone">Gestrinone</a></li>
<li><a href="Levonorgestrel.htm" tppabs="https://ptable.com/wiki/compounds/A/Levonorgestrel" title="Levonorgestrel">Levonorgestrel</a><sup>#</sup></li>
<li>Norelgestromin</li>
<li><a href="Norgestimate.htm" tppabs="https://ptable.com/wiki/compounds/A/Norgestimate" title="Norgestimate">Norgestimate</a></li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Norgestrel  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Norgestrel'" tppabs="https://ptable.com/wiki/compounds/A/Norgestrel" title="Norgestrel">Norgestrel</a></li></ul>

<ul><li><i>Spirolactone derivatives:</i> <a href="Drospirenone.htm" tppabs="https://ptable.com/wiki/compounds/A/Drospirenone" title="Drospirenone">Drospirenone</a></li></ul>

<ul><li><i>Others:</i> Anabolic–androgenic steroids (e.g., <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Nandrolone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Nandrolone'" tppabs="https://ptable.com/wiki/compounds/A/Nandrolone" title="Nandrolone">nandrolone</a> and esters, trenbolone and esters, <a href="Ethylestrenol.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethylestrenol" title="Ethylestrenol">ethylestrenol</a>, norethandrolone, others)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Antiprogestogens</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;background:#DDDDFF;"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:8em;;text-align:center;"><abbr>SPRMs</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Telapristone<sup>§</sup></li>
<li>Ulipristal acetate</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:8em;;text-align:center;"><abbr>PR</abbr> antagonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Aglepristone</li>
<li><a href="Mifepristone.htm" tppabs="https://ptable.com/wiki/compounds/A/Mifepristone" title="Mifepristone">Mifepristone</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td colspan="2" class="navbox-list navbox-even hlist" style="width:100%;padding:0px;background:#DDDDFF;"><div style="padding:0em 0.25em"><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div>
<dl><dt>See also</dt>
<dd>Progesterone receptor modulators</dd>
<dd>Androgens and antiandrogens</dd>
<dd>Estrogens and antiestrogens</dd>
<dd>List of progestogens</dd></dl></div></td></tr></tbody></table></div><span>
</span>
<div role="navigation" class="navbox" aria-labelledby="Progesterone_receptor_modulators" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Progesterone_receptor_modulators" style="font-size:114%;margin:0 4em">Progesterone receptor modulators</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>PR</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Agonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Progesterone derivatives:</i> 3β-Dihydroprogesterone</li>
<li><a href="5α-Dihydroprogesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/5%CE%B1-Dihydroprogesterone" title="5α-Dihydroprogesterone">5α-Dihydroprogesterone</a></li>
<li>6α-Methylprogesterone</li>
<li>9α-Bromo-11-ketoprogesterone</li>
<li>11-Dehydroprogesterone</li>
<li><a href="11-Deoxycorticosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/11-Deoxycorticosterone" title="11-Deoxycorticosterone">11-Deoxycorticosterone</a></li>
<li>16α-Hydroxyprogesterone</li>
<li><span class="new">17α-Methyl-11-deoxycorticosterone acetate</span></li>
<li>20α-Dihydroprogesterone</li>
<li>20β-Dihydroprogesterone</li>
<li>Dimepregnen</li>
<li><a href="Diosgenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Diosgenin" title="Diosgenin">Diosgenin</a></li>
<li>P1-185</li>
<li><a href="Progesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Progesterone" title="Progesterone">Progesterone</a></li>
<li>Progesterone 3-acetyl enol ether</li>
<li>Quingestrone</li></ul>

<ul><li><i>Retroprogesterone derivatives:</i> 20α-Dihydrodydrogesterone</li>
<li>20α-Dihydrotrengestone</li>
<li>DU-41164</li>
<li>DU-41165</li>
<li><a href="Dydrogesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dydrogesterone" title="Dydrogesterone">Dydrogesterone</a></li>
<li>Retroprogesterone</li>
<li>Ro 6-3129</li>
<li>Trengestone</li></ul>

<ul><li><i>17α-Substituted progesterone derivatives:</i> 6α-Methyl-17α-bromoprogesterone</li>
<li>15β-Hydroxycyproterone acetate</li>
<li>16-Methylene-17α-hydroxyprogesterone acetate</li>
<li>17α-Bromoprogesterone</li>
<li>17α-Hydroxyprogesterone (hydroxyprogesterone)</li>
<li>17α-Methylprogesterone</li>
<li>Acetomepregenol (mepregenol diacetate)</li>
<li>Algestone</li>
<li>Algestone acetonide</li>
<li>Algestone acetophenide</li>
<li>Anagestone</li>
<li>Anagestone acetate</li>
<li><span class="new">Bromethenmadinone</span></li>
<li>Bromethenmadinone acetate</li>
<li>Butagest (buterol)</li>
<li>Chlormadinone</li>
<li>Chlormadinone acetate</li>
<li>Chlormadinone caproate</li>
<li><span class="new">Chlormethenmadinone</span></li>
<li>Chlormethenmadinone acetate</li>
<li>Cismadinone</li>
<li>Cismadinone acetate</li>
<li>Clogestone</li>
<li>Clogestone acetate</li>
<li>Clomegestone</li>
<li>Clomegestone acetate</li>
<li>Cymegesolate</li>
<li>Cyproterone acetate</li>
<li>Delmadinone</li>
<li>Delmadinone acetate</li>
<li>Edogestrone</li>
<li>Flugestone</li>
<li>Flugestone acetate</li>
<li><a href="Fluorometholone.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluorometholone" title="Fluorometholone">Fluorometholone</a></li>
<li>Fluorometholone acetate</li>
<li>Flumedroxone</li>
<li>Flumedroxone acetate</li>
<li>Fluoromedroxyprogesterone acetate</li>
<li>Gestaclone</li>
<li>Haloprogesterone</li>
<li>Hydromadinone</li>
<li>Hydromadinone acetate</li>
<li>Hydroxyprogesterone acetate</li>
<li>Hydroxyprogesterone caproate (hydroxyprogesterone hexanoate)</li>
<li>Hydroxyprogesterone heptanoate (hydroxyprogesterone enanthate)</li>
<li>Hydroxyprogesterone heptanoate benzilic acid hydrazone</li>
<li>Mecigestone (pentarane B)</li>
<li>Medrogestone</li>
<li><a href="Medroxyprogesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Medroxyprogesterone" title="Medroxyprogesterone">Medroxyprogesterone</a></li>
<li><a href="Medroxyprogesterone_acetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate">Medroxyprogesterone acetate</a></li>
<li>Medroxyprogesterone caproate</li>
<li><a href="Megestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Megestrol" title="Megestrol">Megestrol</a></li>
<li>Megestrol acetate</li>
<li>Megestrol caproate</li>
<li>Melengestrol</li>
<li>Melengestrol acetate</li>
<li>Methenmadinone</li>
<li>Methenmadinone acetate</li>
<li>Methenmadinone caproate</li>
<li>Mometasone</li>
<li><a href="Mometasone_furoate.htm" tppabs="https://ptable.com/wiki/compounds/A/Mometasone_furoate" title="Mometasone furoate" class="mw-redirect">Mometasone furoate</a></li>
<li>Osaterone</li>
<li>Osaterone acetate</li>
<li>Pentagestrone</li>
<li>Pentagestrone acetate</li>
<li>Pentarane A</li>
<li>Proligestone</li></ul>

<ul><li><i>19-Norprogesterone derivatives:</i> 17α-Methyl-19-norprogesterone</li>
<li>18-Methylsegesterone acetate</li>
<li>19-Norprogesterone</li>
<li>Amadinone</li>
<li>Amadinone acetate</li>
<li>Demegestone</li>
<li><span class="new">Fluoro ethyl norprogesterone</span></li>
<li><span class="new">Fluoro furanyl norprogesterone</span></li>
<li>Gestadienol</li>
<li>Gestadienol acetate</li>
<li>Gestonorone acetate (gestronol acetate)</li>
<li>Gestonorone caproate (gestronol hexanoate)</li>
<li>Gestronol (gestonorone)</li>
<li>Nomegestrol</li>
<li>Nomegestrol acetate</li>
<li>Norgestomet</li>
<li>ORG-2058</li>
<li>Oxogestone</li>
<li>Oxogestone phenpropionate (xinogestone)</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Promegestone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Promegestone'" tppabs="https://ptable.com/wiki/compounds/A/Promegestone" title="Promegestone">Promegestone</a></li>
<li>Segesterone</li>
<li>Segesterone acetate (nestorone)</li>
<li>Trimegestone</li></ul>

<ul><li><i>Testosterone derivatives:</i> Progestins: 6,6-Difluoronorethisterone</li>
<li>6,6-Difluoronorethisterone acetate</li>
<li>17α-Allyl-19-nortestosterone</li>
<li><a href="Allylestrenol.htm" tppabs="https://ptable.com/wiki/compounds/A/Allylestrenol" title="Allylestrenol">Allylestrenol</a></li>
<li>Altrenogest</li>
<li>Chloroethynylnorgestrel</li>
<li>Cingestol</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Danazol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Danazol'" tppabs="https://ptable.com/wiki/compounds/A/Danazol" title="Danazol">Danazol</a></li>
<li><a href="Desogestrel.htm" tppabs="https://ptable.com/wiki/compounds/A/Desogestrel" title="Desogestrel">Desogestrel</a></li>
<li>Dienogest</li>
<li>Ethinylandrostenediol
<ul><li>Ethandrostate</li></ul></li>
<li><a href="Ethisterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethisterone" title="Ethisterone">Ethisterone</a></li>
<li>Ethynerone</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Etonogestrel  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Etonogestrel'" tppabs="https://ptable.com/wiki/compounds/A/Etonogestrel" title="Etonogestrel">Etonogestrel</a></li>
<li>Etynodiol</li>
<li><a href="Etynodiol_diacetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Etynodiol_diacetate" title="Etynodiol diacetate">Etynodiol diacetate</a></li>
<li><a href="Gestodene.htm" tppabs="https://ptable.com/wiki/compounds/A/Gestodene" title="Gestodene">Gestodene</a></li>
<li><a href="Gestrinone.htm" tppabs="https://ptable.com/wiki/compounds/A/Gestrinone" title="Gestrinone">Gestrinone</a></li>
<li><a href="Levonorgestrel.htm" tppabs="https://ptable.com/wiki/compounds/A/Levonorgestrel" title="Levonorgestrel">Levonorgestrel</a></li>
<li>Levonorgestrel esters (e.g., levonorgestrel butanoate)</li>
<li>Lynestrenol</li>
<li>Lynestrenol phenylpropionate</li>
<li>Metynodiol</li>
<li>Metynodiol diacetate</li>
<li>Norelgestromin</li>
<li><a href="Norethisterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Norethisterone" title="Norethisterone">Norethisterone (norethindrone)</a></li>
<li>Norethisterone esters (e.g., norethisterone acetate, norethisterone enanthate)</li>
<li>Noretynodrel</li>
<li>Norgesterone</li>
<li><a href="Norgestimate.htm" tppabs="https://ptable.com/wiki/compounds/A/Norgestimate" title="Norgestimate">Norgestimate</a></li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Norgestrel  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Norgestrel'" tppabs="https://ptable.com/wiki/compounds/A/Norgestrel" title="Norgestrel">Norgestrel</a></li>
<li>Norgestrienone</li>
<li>Norvinisterone</li>
<li>Oxendolone</li>
<li>Quingestanol</li>
<li>Quingestanol acetate</li>
<li>Tibolone</li>
<li>Tigestol</li>
<li>Tosagestin; Anabolic–androgenic steroids: 11β-Methyl-19-nortestosterone</li>
<li>11β-Methyl-19-nortestosterone dodecylcarbonate</li>
<li>19-Nor-5-androstenediol</li>
<li>19-Nor-5-androstenedione</li>
<li>19-Nordehydroepiandrosterone</li>
<li>Bolandiol</li>
<li>Bolandiol dipropionate</li>
<li>Bolandione</li>
<li>Dimethisterone</li>
<li>Dienedione</li>
<li>Dienolone</li>
<li>Dimethandrolone</li>
<li>Dimethandrolone buciclate</li>
<li>Dimethandrolone dodecylcarbonate</li>
<li>Dimethandrolone undecanoate</li>
<li>Dimethyldienolone</li>
<li>Dimethyltrienolone</li>
<li>Ethyldienolone</li>
<li><a href="Ethylestrenol.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethylestrenol" title="Ethylestrenol">Ethylestrenol (ethylnandrol)</a></li>
<li>Methyldienolone</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Metribolone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Metribolone'" tppabs="https://ptable.com/wiki/compounds/A/Metribolone" title="Metribolone">Metribolone (R-1881)</a></li>
<li>Methoxydienone (methoxygonadiene)</li>
<li>Mibolerone</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Nandrolone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Nandrolone'" tppabs="https://ptable.com/wiki/compounds/A/Nandrolone" title="Nandrolone">Nandrolone</a></li>
<li>Nandrolone esters (e.g., nandrolone decanoate, nandrolone phenylpropionate)</li>
<li>Norethandrolone</li>
<li>Normethandrone (methylestrenolone, normethandrolone, normethisterone)</li>
<li>RU-2309</li>
<li>Tetrahydrogestrinone</li>
<li>Trenbolone (trienolone)</li>
<li>Trenbolone esters (e.g., trenbolone acetate, trenbolone enanthate)</li>
<li>Trendione</li>
<li>Trestolone</li>
<li>Trestolone acetate</li></ul>

<ul><li><i>Spirolactone derivatives:</i> Canrenoic acid</li>
<li>Canrenone</li>
<li><a href="Drospirenone.htm" tppabs="https://ptable.com/wiki/compounds/A/Drospirenone" title="Drospirenone">Drospirenone</a></li>
<li>Mespirenone</li>
<li>Potassium canrenoate</li>
<li>Prorenone</li>
<li>SC-5233 (spirolactone)</li>
<li>SC-8109</li>
<li><a href="Spironolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Spironolactone" title="Spironolactone">Spironolactone</a></li>
<li>Spirorenone</li></ul>

<ul><li><i>Nonsteroidal:</i> 3,8-Dihydrodiligustilide</li>
<li>LG-2527</li>
<li><span class="new">LG-100128</span></li>
<li>Riligustilide</li>
<li><span class="new">RWJ-26819</span></li>
<li><span class="new">RWJ-49853</span></li>
<li><span class="new">RWJ-60130</span></li>
<li>Tanaproget</li>
<li>ZM-182345</li></ul>

<ul><li><i>Unknown:</i> ORG-47241</li>
<li>ORG-201745</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Mixed<br>(<abbr>SPRMs</abbr>)</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Steroidal:</i> Dihydroethisterone</li>
<li>5α-Dihydrolevonorgestrel</li>
<li>5α-Dihydronorethisterone</li>
<li>Asoprisnil</li>
<li>Asoprisnil ecamate</li>
<li>Guggulsterone</li>
<li><span class="new">J1042</span></li>
<li><span class="new">LG-120838</span></li>
<li>Metapristone (RU-42633)</li>
<li><a href="Mifepristone.htm" tppabs="https://ptable.com/wiki/compounds/A/Mifepristone" title="Mifepristone">Mifepristone (RU-486)</a></li>
<li><span class="new">ORF-9371</span></li>
<li>ORF-9326</li>
<li><span class="new">ORG-31710</span></li>
<li><span class="new">ORG-33628</span></li>
<li><span class="new">RMI-12936</span></li>
<li>Telapristone</li>
<li>Ulipristal acetate</li>
<li>Vilaprisan</li>
<li><span class="new">ZK-137316</span></li></ul>

<ul><li><i>Nonsteroidal:</i> <a href="Apigenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Apigenin" title="Apigenin">Apigenin</a></li>
<li><a href="Kaempferol.htm" tppabs="https://ptable.com/wiki/compounds/A/Kaempferol" title="Kaempferol">Kaempferol</a></li>
<li><span class="new">LG-120920</span></li>
<li><a href="Naringenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Naringenin" title="Naringenin">Naringenin</a></li>
<li><span class="new">PRA-910</span></li>
<li><a href="Syringic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Syringic_acid" title="Syringic acid">Syringic acid</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Antagonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Steroidal:</i> Aglepristone</li>
<li>Lilopristone</li>
<li>Lonaprisan</li>
<li>Onapristone</li>
<li><span class="new">ORG-31710</span></li>
<li><span class="new">ORG-31806</span></li>
<li><span class="new">ORG-33628</span></li>
<li><span class="new">RTI 3021–022</span></li>
<li>Toripristone</li>
<li>Zanoterone</li></ul>

<ul><li><i>Nonsteroidal:</i> Darolutamide</li>
<li><span class="new">LG-001447</span></li>
<li><span class="new">LG-100127</span></li>
<li><span class="new">LG-100128</span></li>
<li><span class="new">LG-120830</span></li>
<li><span class="new">LG-121046</span></li>
<li><a href="Valproic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Valproic_acid" title="Valproic acid" class="mw-redirect">Valproic acid</a></li>
<li><span class="new">ZM-150271</span></li>
<li><span class="new">ZM-172406</span></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>mPR</abbr><br>(<abbr>PAQR</abbr>)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Agonists</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="5α-Dihydroprogesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/5%CE%B1-Dihydroprogesterone" title="5α-Dihydroprogesterone">5α-Dihydroprogesterone</a></li>
<li>5β-Dihydroprogesterone</li>
<li><a href="11-Deoxycorticosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/11-Deoxycorticosterone" title="11-Deoxycorticosterone">11-Deoxycortisone (21-hydroxyprogesterone)</a></li>
<li>11-Deoxycortisol (17α,21-dihydroxyprogesterone)</li>
<li>17α-Hydroxyprogesterone</li>
<li><a href="Allopregnanolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Allopregnanolone" title="Allopregnanolone">Allopregnanolone</a></li>
<li><a href="Mifepristone.htm" tppabs="https://ptable.com/wiki/compounds/A/Mifepristone" title="Mifepristone">Mifepristone</a></li>
<li><a href="Pregnenolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Pregnenolone" title="Pregnenolone">Pregnenolone</a></li>
<li><a href="Progesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Progesterone" title="Progesterone">Progesterone</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Antagonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Mifepristone.htm" tppabs="https://ptable.com/wiki/compounds/A/Mifepristone" title="Mifepristone">Mifepristone</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div>
<dl><dt>See also</dt>
<dd>Receptor/signaling modulators</dd>
<dd>Progestogens and antiprogestogens</dd>
<dd>Androgen receptor modulators</dd>
<dd>Estrogen receptor modulators</dd>
<dd>List of progestogens</dd></dl>
</div></td></tr></tbody></table></div><span>
</span>
<div role="navigation" class="navbox" aria-labelledby="Androgen_receptor_modulators" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Androgen_receptor_modulators" style="font-size:114%;margin:0 4em">Androgen receptor modulators</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>AR</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Agonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Testosterone derivatives:</i> <a href="4-Androstenediol.htm" tppabs="https://ptable.com/wiki/compounds/A/4-Androstenediol" title="4-Androstenediol">4-Androstenediol</a></li>
<li>4-Dehydroepiandrosterone (4-DHEA)</li>
<li>4-Hydroxytestosterone</li>
<li><span class="new">4,17α-Dimethyltestosterone</span></li>
<li>5-Androstenedione</li>
<li>11-Ketotestosterone</li>
<li>11β-Hydroxyandrostenedione</li>
<li><a href="Adrenosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Adrenosterone" title="Adrenosterone">Adrenosterone (11-ketoandrostenedione, 11-oxoandrostenedione)</a></li>
<li><a href="5-Androstenediol.htm" tppabs="https://ptable.com/wiki/compounds/A/5-Androstenediol" title="5-Androstenediol" class="mw-redirect">Androstenediol (5-androstenediol)</a>
<ul><li>Androstenediol 3β-acetate</li>
<li>Androstenediol 17β-acetate</li>
<li>Androstenediol diacetate</li>
<li>Androstenediol dipropionate</li></ul></li>
<li><a href="Androstenedione.htm" tppabs="https://ptable.com/wiki/compounds/A/4-Androstenedione" title="4-Androstenedione" class="mw-redirect">Androstenedione (4-androstenedione)</a></li>
<li>Atamestane</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Boldenone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Boldenone'" tppabs="https://ptable.com/wiki/compounds/A/Boldenone" title="Boldenone">Boldenone</a>
<ul><li>Boldenone undecylenate</li></ul></li>
<li>Boldione (1,4-androstadienedione)</li>
<li><a href="Clostebol.htm" tppabs="https://ptable.com/wiki/compounds/A/Clostebol" title="Clostebol">Clostebol</a>
<ul><li>Clostebol acetate</li>
<li>Clostebol caproate</li>
<li>Clostebol propionate</li></ul></li>
<li>Cloxotestosterone
<ul><li>Cloxotestosterone acetate</li></ul></li>
<li>Dehydroandrosterone</li>
<li><a href="Dehydroepiandrosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dehydroepiandrosterone" title="Dehydroepiandrosterone">DHEA (androstenolone, prasterone; 5-DHEA)</a>
<ul><li>DHEA enanthate (prasterone enanthate)</li>
<li><a href="Dehydroepiandrosterone_sulfate.htm" tppabs="https://ptable.com/wiki/compounds/A/Dehydroepiandrosterone_sulfate" title="Dehydroepiandrosterone sulfate">DHEA sulfate</a></li></ul></li>
<li><a href="Exemestane.htm" tppabs="https://ptable.com/wiki/compounds/A/Exemestane" title="Exemestane">Exemestane</a></li>
<li><a href="Formestane.htm" tppabs="https://ptable.com/wiki/compounds/A/Formestane" title="Formestane">Formestane</a></li>
<li>Plomestane</li>
<li>Quinbolone</li>
<li>Silandrone</li>
<li>Testosterone<sup>#</sup> (+dutasteride)
<ul><li>Testosterone esters</li>
<li>Polytestosterone phloretin phosphate</li></ul></li></ul>

<ul><li><i>5α-Dihydrotestosterone derivatives:</i> 1-Androstenediol</li>
<li>1-Androstenedione</li>
<li>1-Androsterone (1-andro, 1-DHEA)</li>
<li>1-Testosterone</li>
<li>3α-Androstanediol</li>
<li>5α-Androst-2-en-17-one</li>
<li>7β-Hydroxyepiandrosterone</li>
<li>11-Ketodihydrotestosterone</li>
<li><a href="Androsterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Androsterone" title="Androsterone">Androsterone</a></li>
<li>Bolazine
<ul><li>Bolazine capronate</li></ul></li>
<li><span class="new">Dihydroethyltestosterone</span></li>
<li>Dihydrofluoxymesterone</li>
<li><span class="new">Dihydromethylandrostenediol</span></li>
<li><a href="Dihydrotestosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydrotestosterone" title="Dihydrotestosterone">Dihydrotestosterone (DHT)</a> (androstanolone, stanolone)
<ul><li>Dihydrotestosterone esters</li></ul></li>
<li><a href="Drostanolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Drostanolone" title="Drostanolone">Drostanolone</a>
<ul><li>Drostanolone propionate</li></ul></li>
<li><a href="Epiandrosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Epiandrosterone" title="Epiandrosterone">Epiandrosterone</a></li>
<li>Epitiostanol</li>
<li>Mepitiostane</li>
<li>Mesabolone</li>
<li><a href="Mesterolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Mesterolone" title="Mesterolone">Mesterolone</a>
<ul><li>Mesterolone cipionate</li></ul></li>
<li>Methyldiazinol</li>
<li>Nisterime
<ul><li>Nisterime acetate</li></ul></li>
<li>Prostanozol</li>
<li>Stenbolone
<ul><li>Stenbolone acetate</li></ul></li>
<li>Testifenon (testiphenon, testiphenone)</li></ul>

<ul><li><i>19-Nortestosterone derivatives:</i> 7α-Methyl-19-norandrostenedione (MENT dione, trestione)</li>
<li>11β-Methyl-19-nortestosterone
<ul><li>11β-Methyl-19-nortestosterone dodecylcarbonate</li></ul></li>
<li>19-Nor-5-androstenediol</li>
<li>19-Nor-5-androstenedione</li>
<li>19-Nordehydroepiandrosterone</li>
<li>Bolandiol
<ul><li>Bolandiol dipropionate</li></ul></li>
<li>Bolandione (19-nor-4-androstenedione)</li>
<li>Bolmantalate (nandrolone adamantoate)</li>
<li>Dienedione</li>
<li>Dienolone</li>
<li>Dimethandrolone
<ul><li>Dimethandrolone buciclate</li>
<li>Dimethandrolone dodecylcarbonate</li>
<li>Dimethandrolone undecanoate</li></ul></li>
<li>LS-1727 (nandrolone 17β-<i>N</i>-(2-chloroethyl)-<i>N</i>-nitrosocarbamate)</li>
<li>Methoxydienone (methoxygonadiene)</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Nandrolone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Nandrolone'" tppabs="https://ptable.com/wiki/compounds/A/Nandrolone" title="Nandrolone">Nandrolone</a>
<ul><li>Nandrolone esters</li></ul></li>
<li>Norclostebol
<ul><li>Norclostebol acetate</li></ul></li>
<li>Normethandrone (methylestrenolone, normethisterone)</li>
<li><a href="Oxabolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxabolone" title="Oxabolone">Oxabolone</a>
<ul><li><a href="Oxabolone_cipionate.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxabolone_cipionate" title="Oxabolone cipionate">Oxabolone cipionate (oxabolone cypionate)</a></li></ul></li>
<li>Trenbolone
<ul><li>Trenbolone acetate</li>
<li>Trenbolone enanthate</li>
<li>Trenbolone hexahydrobenzylcarbonate</li>
<li>Trenbolone undecanoate</li></ul></li>
<li>Trendione</li>
<li>Trestolone (MENT)
<ul><li>Trestolone acetate</li>
<li>Trestolone enanthate</li></ul></li></ul>

<ul><li><i>5α-Dihydro-19-nortestosterone derivatives:</i> 5α-Dihydronandrolone</li>
<li><span class="new">5α-Dihydrotrestolone</span></li>
<li>19-Norandrosterone</li></ul>

<ul><li><i>17α-Alkylated testosterone derivatives:</i> <a href="Bolasterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Bolasterone" title="Bolasterone">Bolasterone</a></li>
<li><a href="Calusterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Calusterone" title="Calusterone">Calusterone</a></li>
<li>Chlorodehydromethylandrostenediol (CDMA)</li>
<li>Chlorodehydromethyltestosterone (CDMT)</li>
<li>Chloromethylandrostenediol (CMA)</li>
<li>Enestebol</li>
<li>Ethyltestosterone</li>
<li><a href="Fluoxymesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluoxymesterone" title="Fluoxymesterone">Fluoxymesterone</a></li>
<li><a href="Formebolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Formebolone" title="Formebolone">Formebolone</a></li>
<li>Hydroxystenozole</li>
<li>Metandienone (methandrostenolone)</li>
<li>Methandriol (methylandrostenediol)
<ul><li>Methandriol bisenanthoyl acetate</li>
<li>Methandriol diacetate</li>
<li>Methandriol dipropionate</li>
<li>Methandriol propionate</li></ul></li>
<li>Methylclostebol (chloromethyltestosterone)</li>
<li><a href="Methyltestosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Methyltestosterone" title="Methyltestosterone">Methyltestosterone</a> (+esterified estrogens)
<ul><li>Methyltestosterone 3-hexyl ether</li></ul></li>
<li>Oxymesterone</li>
<li>Penmesterol</li>
<li>Tiomesterone</li></ul>

<ul><li><i>17α-Alkylated 5α-dihydrotestosterone derivatives:</i> Androisoxazole</li>
<li>Desoxymethyltestosterone</li>
<li><a href="Furazabol.htm" tppabs="https://ptable.com/wiki/compounds/A/Furazabol" title="Furazabol">Furazabol</a></li>
<li>Mebolazine (dimethazine)</li>
<li><a href="Mestanolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Mestanolone" title="Mestanolone">Mestanolone</a></li>
<li>Metenolone
<ul><li>Metenolone acetate</li>
<li>Metenolone enanthate</li></ul></li>
<li>Methasterone</li>
<li>Methyl-1-testosterone</li>
<li>Methylepitiostanol</li>
<li>Methylstenbolone</li>
<li><a href="Oxandrolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxandrolone" title="Oxandrolone">Oxandrolone</a></li>
<li><a href="Oxymetholone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxymetholone" title="Oxymetholone">Oxymetholone</a></li>
<li><a href="Stanozolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Stanozolol" title="Stanozolol">Stanozolol</a></li></ul>

<ul><li><i>17α-Alkylated 19-nortestosterone derivatives:</i> Bolenol</li>
<li>Dimethyldienolone</li>
<li>Dimethyltrienolone</li>
<li>Ethyldienolone</li>
<li><a href="Ethylestrenol.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethylestrenol" title="Ethylestrenol">Ethylestrenol</a></li>
<li>Methyldienolone</li>
<li>Methylhydroxynandrolone (MOHN, MHN)</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Metribolone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Metribolone'" tppabs="https://ptable.com/wiki/compounds/A/Metribolone" title="Metribolone">Metribolone</a></li>
<li>Mibolerone</li>
<li>Norboletone</li>
<li>Norethandrolone</li>
<li>Propetandrol</li>
<li>RU-2309</li>
<li>Tetrahydrogestrinone</li></ul>

<ul><li><i>17α-Alkylated 5α-dihydro-19-nortestosterone derivatives:</i> 5α-Dihydronorethandrolone</li>
<li>5α-Dihydronormethandrone</li></ul>

<ul><li><i>17α-Vinyltestosterone derivatives:</i> Norvinisterone (vinylnortestosterone)</li></ul>

<ul><li><i>17α-Vinyl-19-nortestosterone derivatives:</i> Vinyltestosterone</li></ul>

<ul><li><i>17α-Ethynyltestosterone derivatives:</i> <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Danazol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Danazol'" tppabs="https://ptable.com/wiki/compounds/A/Danazol" title="Danazol">Danazol</a></li>
<li>Ethinylandrostenediol
<ul><li>Ethandrostate</li></ul></li>
<li><a href="Ethisterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethisterone" title="Ethisterone">Ethisterone (ethynyltestosterone)</a></li></ul>

<ul><li><i>5α-Dihydro-17α-ethynyltestosterone derivatives:</i> 17α-Ethynyl-3α-androstanediol</li>
<li>17α-Ethynyl-3β-androstanediol</li>
<li>Dihydroethisterone</li></ul>

<ul><li><i>17α-Ethynyl-19-nortestosterone derivatives:</i> Δ<sup>4</sup>-Tibolone</li>
<li><a href="Desogestrel.htm" tppabs="https://ptable.com/wiki/compounds/A/Desogestrel" title="Desogestrel">Desogestrel</a></li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Etonogestrel  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Etonogestrel'" tppabs="https://ptable.com/wiki/compounds/A/Etonogestrel" title="Etonogestrel">Etonogestrel</a></li>
<li>Etynodiol
<ul><li><a href="Etynodiol_diacetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Etynodiol_diacetate" title="Etynodiol diacetate">Etynodiol diacetate</a></li></ul></li>
<li><a href="Gestodene.htm" tppabs="https://ptable.com/wiki/compounds/A/Gestodene" title="Gestodene">Gestodene</a></li>
<li><a href="Gestrinone.htm" tppabs="https://ptable.com/wiki/compounds/A/Gestrinone" title="Gestrinone">Gestrinone</a></li>
<li><a href="Levonorgestrel.htm" tppabs="https://ptable.com/wiki/compounds/A/Levonorgestrel" title="Levonorgestrel">Levonorgestrel</a></li>
<li>Levonorgestrel esters (e.g., levonorgestrel butanoate)</li>
<li>Lynestrenol
<ul><li>Lynestrenol phenylpropionate</li></ul></li>
<li><a href="Norethisterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Norethisterone" title="Norethisterone">Norethisterone</a></li>
<li>Norethisterone esters (e.g., norethisterone acetate, norethisterone enanthate)</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Norgestrel  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Norgestrel'" tppabs="https://ptable.com/wiki/compounds/A/Norgestrel" title="Norgestrel">Norgestrel</a></li>
<li>Norgestrienone</li>
<li>Quingestanol
<ul><li>Quingestanol acetate</li></ul></li>
<li>Tibolone</li></ul>

<ul><li><i>5α-Dihydro-17α-ethynyl-19-nortestosterone derivatives:</i> 5α-Dihydrolevonorgestrel</li>
<li>5α-Dihydronorethisterone</li></ul>

<ul><li><i>Progesterone derivatives:</i> 6α-Methylprogesterone</li>
<li><a href="Medroxyprogesterone_acetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate">Medroxyprogesterone acetate</a></li>
<li>Megestrol acetate</li></ul>

<ul><li><i>Others/unsorted:</i> 3-Keto-5α-abiraterone</li>
<li><a href="Androstane.htm" tppabs="https://ptable.com/wiki/compounds/A/5%CE%B1-Androstane" title="5α-Androstane" class="mw-redirect">5α-Androstane</a></li>
<li>Alternariol</li>
<li>Cl-4AS-1</li>
<li>Drupanol</li>
<li><a href="Trilostane.htm" tppabs="https://ptable.com/wiki/compounds/A/Trilostane" title="Trilostane">Trilostane</a></li>
<li>ZM-182345</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Mixed<br>(<abbr>SARMs</abbr>)</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Nonsteroidal:</i> <span class="new">198RL26</span></li>
<li><span class="new">ACP-105</span></li>
<li><span class="new">AC-262536</span></li>
<li>Acetothiolutamide</li>
<li>Andarine (acetamidoxolutamide, androxolutamide, GTx-007, S-4)</li>
<li><span class="new">BMS-564929</span></li>
<li><span class="new">DTIB</span></li>
<li>Enobosarm (ostarine, MK-2866, GTx-024, S-22)</li>
<li><span class="new">FTBU-1</span></li>
<li>GSK2881078</li>
<li><span class="new">GSK-4336A</span></li>
<li><span class="new">GSK-8698</span></li>
<li>LG-121071 (LGD-121071)</li>
<li>LGD-2226</li>
<li><span class="new">LGD-2941 (LGD-122941)</span></li>
<li>LGD-3303</li>
<li>LGD-4033</li>
<li>LY-2452473</li>
<li><span class="new">JNJ-26146900</span></li>
<li>JNJ-28330835</li>
<li><span class="new">JNJ-37654032</span></li>
<li><span class="new">ORM-11984</span></li>
<li><span class="new">R-1</span></li>
<li>RAD140</li>
<li>RU-59063</li>
<li><span class="new">S-1</span></li>
<li>S-23</li>
<li>S-40503</li>
<li><span class="new">S-101479</span></li>
<li>Triclosan</li></ul>

<ul><li><i>Steroidal:</i> <span class="new">EM-9017</span></li>
<li>MK-0773</li>
<li>TFM-4AS-1</li>
<li>YK-11</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Antagonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Steroidal:</i> 7α-Thioprogesterone</li>
<li>7α-Thiospironolactone</li>
<li>7α-Thiomethylspironolactone</li>
<li>11α-Hydroxyprogesterone</li>
<li>15β-Hydroxycyproterone acetate</li>
<li>Abiraterone</li>
<li>Abiraterone acetate</li>
<li>Allyltestosterone</li>
<li>Benorterone</li>
<li>BOMT</li>
<li>Canrenoic acid</li>
<li>Canrenone</li>
<li>Chlormadinone acetate</li>
<li>Clascoterone</li>
<li>Clometerone</li>
<li><a href="Cyproheptadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyproheptadine" title="Cyproheptadine">Cyproheptadine</a></li>
<li><a href="Cyproterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyproterone" title="Cyproterone">Cyproterone</a></li>
<li>Cyproterone acetate</li>
<li>Delanterone</li>
<li>Delmadinone acetate</li>
<li>Dicirenone</li>
<li>Dienogest</li>
<li><a href="Drospirenone.htm" tppabs="https://ptable.com/wiki/compounds/A/Drospirenone" title="Drospirenone">Drospirenone</a></li>
<li>DU-41165</li>
<li>Edogestrone</li>
<li><span class="new">EM-4350</span></li>
<li>EM-5854</li>
<li><span class="new">EM-5855</span></li>
<li><span class="new">EM-6537</span></li>
<li>Epitestosterone</li>
<li>Galeterone</li>
<li>Guggulsterone</li>
<li>Medrogestone</li>
<li>Megestrol acetate</li>
<li>Mespirenone</li>
<li>Metogest</li>
<li>Mexrenone</li>
<li><a href="Mifepristone.htm" tppabs="https://ptable.com/wiki/compounds/A/Mifepristone" title="Mifepristone">Mifepristone</a></li>
<li>Nomegestrol acetate</li>
<li>Nordinone</li>
<li>Osaterone</li>
<li>Osaterone acetate</li>
<li>Oxendolone</li>
<li>Potassium canrenoate</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Promegestone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Promegestone'" tppabs="https://ptable.com/wiki/compounds/A/Promegestone" title="Promegestone">Promegestone</a></li>
<li>Prorenone</li>
<li>Rosterolone</li>
<li><span class="new">RU-15328</span></li>
<li>SC-5233 (spirolactone)</li>
<li><a href="Spironolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Spironolactone" title="Spironolactone">Spironolactone</a></li>
<li>Spirorenone</li>
<li>Spiroxasone</li>
<li>Topterone</li>
<li>Trimegestone</li>
<li>Trimethyltrienolone (R-2956)</li>
<li>Zanoterone</li></ul>

<ul><li><i>Nonsteroidal:</i> 5<i>N</i>-Bicalutamide</li>
<li>AA560</li>
<li><span class="new">Antarlides</span></li>
<li><span class="new">Arabilin</span></li>
<li>Apalutamide</li>
<li>Atraric acid</li>
<li><span class="new">AZD-3514</span></li>
<li>Bakuchiol</li>
<li><span class="new">BAY-1024767</span></li>
<li><a href="Bicalutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Bicalutamide" title="Bicalutamide">Bicalutamide</a></li>
<li><a href="Bisphenol.htm" tppabs="https://ptable.com/wiki/compounds/A/Bisphenol" title="Bisphenol">Bisphenols</a> (e.g., <a href="Bisphenol_A_diglycidyl_ether.htm" tppabs="https://ptable.com/wiki/compounds/A/Bisphenol_A_diglycidyl_ether" title="Bisphenol A diglycidyl ether">BADGE</a>, <span class="new">BFDGE</span>, <a href="Bisphenol_A.htm" tppabs="https://ptable.com/wiki/compounds/A/Bisphenol_A" title="Bisphenol A">bisphenol A</a>, bisphenol F, <a href="Bisphenol_S.htm" tppabs="https://ptable.com/wiki/compounds/A/Bisphenol_S" title="Bisphenol S">bisphenol S</a>)</li>
<li><span class="new">BMS-501949</span></li>
<li><span class="new">BMS-570511</span></li>
<li>BMS-641988</li>
<li><span class="new">CH5137291</span></li>
<li><a href="Cimetidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cimetidine" title="Cimetidine">Cimetidine</a></li>
<li>Cioteronel</li>
<li>Cyanonilutamide</li>
<li>Darolutamide</li>
<li>DDT (via metabolite p,p’-DDE)</li>
<li><a href="Dieldrin.htm" tppabs="https://ptable.com/wiki/compounds/A/Dieldrin" title="Dieldrin">Dieldrin</a></li>
<li>DIMP</li>
<li><a href="Endosulfan.htm" tppabs="https://ptable.com/wiki/compounds/A/Endosulfan" title="Endosulfan">Endosulfan</a></li>
<li>Enzalutamide</li>
<li>EPI-001</li>
<li>EPI-7386</li>
<li><a href="Fenarimol.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenarimol" title="Fenarimol">Fenarimol</a></li>
<li><a href="Flutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Flutamide" title="Flutamide">Flutamide</a></li>
<li>Hydroxyflutamide</li>
<li>Inocoterone</li>
<li>Inocoterone acetate</li>
<li><a href="Ketoconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketoconazole" title="Ketoconazole">Ketoconazole</a></li>
<li>Ketodarolutamide</li>
<li>Lavender oil</li>
<li><span class="new">LG-105</span></li>
<li>LG-120907</li>
<li><span class="new">LGD-1331</span></li>
<li>Linuron</li>
<li><a href="Methiocarb.htm" tppabs="https://ptable.com/wiki/compounds/A/Methiocarb" title="Methiocarb">Methiocarb</a></li>
<li><span class="new"><i>N</i>-Butylbenzenesulfonamide</span></li>
<li><i>N</i>-Desmethylapalutamide</li>
<li><i>N</i>-Desmethylenzalutamide</li>
<li><a href="Nilutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nilutamide" title="Nilutamide">Nilutamide</a></li>
<li><span class="new">ONC1-13B</span></li>
<li>Pentomone</li>
<li><span class="new">PF-998425</span></li>
<li><a href="Phenothrin.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenothrin" title="Phenothrin">Phenothrin</a></li>
<li>Prochloraz</li>
<li><a href="Procymidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Procymidone" title="Procymidone">Procymidone</a></li>
<li>Proxalutamide</li>
<li>Ralaniten (EPI-002)</li>
<li>Ralaniten acetate (EPI-506)</li>
<li>RD-162</li>
<li><span class="new">Ro 2-7239</span></li>
<li><span class="new">Ro 5-2537</span></li>
<li>RU-22930</li>
<li>RU-56187</li>
<li>RU-57073</li>
<li>RU-58642</li>
<li>RU-58841</li>
<li>Seviteronel</li>
<li><a href="Thalidomide.htm" tppabs="https://ptable.com/wiki/compounds/A/Thalidomide" title="Thalidomide">Thalidomide</a></li>
<li>Topilutamide (fluridil)</li>
<li><a href="Valproic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Valproic_acid" title="Valproic acid" class="mw-redirect">Valproic acid</a></li>
<li>Vinclozolin</li>
<li><span class="new">YM-580</span></li>
<li><span class="new">YM-92088</span></li>
<li><span class="new">YM-175735</span></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>GPRC6A</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center;">Agonists</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Cations (incl. aluminum, <a href="Calcium.htm" tppabs="https://ptable.com/wiki/compounds/A/Calcium" title="Calcium">calcium</a>, <a href="Gadolinium.htm" tppabs="https://ptable.com/wiki/compounds/A/Gadolinium" title="Gadolinium">gadolinium</a>, <a href="Magnesium.htm" tppabs="https://ptable.com/wiki/compounds/A/Magnesium" title="Magnesium">magnesium</a>, <a href="Strontium.htm" tppabs="https://ptable.com/wiki/compounds/A/Strontium" title="Strontium">strontium</a>, <a href="Zinc.htm" tppabs="https://ptable.com/wiki/compounds/A/Zinc" title="Zinc">zinc</a>)</li>
<li>Dehydroandrosterone</li>
<li><a href="Dihydrotestosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydrotestosterone" title="Dihydrotestosterone">Dihydrotestosterone</a></li>
<li><a href="Estradiol.htm" tppabs="https://ptable.com/wiki/compounds/A/Estradiol" title="Estradiol">Estradiol</a></li>
<li><small>L</small>-α-Amino acids (incl. <a href="Arginine.htm" tppabs="https://ptable.com/wiki/compounds/A/Arginine" title="Arginine"><small>L</small>-arginine</a>, <a href="Lysine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lysine" title="Lysine"><small>L</small>-lysine</a>, <a href="Ornithine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ornithine" title="Ornithine"><small>L</small>-ornithine</a>)</li>
<li>Osteocalcin</li>
<li><abbr>SHBG</abbr></li>
<li><a href="Testosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Testosterone" title="Testosterone">Testosterone</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div>
<dl><dt>See also</dt>
<dd>Receptor/signaling modulators</dd>
<dd>Androgens and antiandrogens</dd>
<dd>Estrogen receptor modulators</dd>
<dd>Progesterone receptor modulators</dd>
<dd>List of androgens/anabolic steroids</dd></dl>
</div></td></tr></tbody></table></div><span>
</span>
















<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>